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ABSTRACT: Stereoselective glycosylation remains the main challenge in the
chemical synthesis of oligosaccharides. Herein we report a simple method to
convert thioglycosides into β-sulfonium ions via an intramolecular alkylation
reaction, leading to highly α-selective glycosylations for a variety of glycosyl
acceptors. The inﬂuence of the thioglycoside substituent and the protecting
group pattern on the glycosyl donor was investigated and showed a clear
correlation with the observed stereoselectivity.
The main challenge of chemical oligosaccharide synthesisis the stereoselective synthesis of glycosidic bonds.1,2 In
general, 1,2-trans-glycosides can be synthesized by exploiting
neighboring group participation of a C-2 acyl group. The
introduction of 1,2-cis-glycosidic linkages is much more
challenging and requires glycosyl donors having a nonassisting
functionality at C-2.3 In general, these glycosylations are less
selective and require optimization to achieve acceptable
anomeric ratios. The development of methodology for
stereoselective 1,2-cis-glycosylation using a generally applicable
principle is therefore highly desirable as it allows for the use of
standardized monosaccharide building blocks. In this respect,
the formation of glycosyl sulfonium ions holds considerable
potential.4−7 In particular, the use of C-2 auxiliaries to attain
highly selective 1,2-cis-glycosylations via neighboring group
participation allows for careful tuning of donor reactivity and
stereoselectivity.8 First reported by Boons et al., C-2 chiral
auxiliaries such as the (S)-(phenylthiomethyl)benzyl ether can
be employed for the stereoselective introduction of 1,2-cis
glycosides such as α-glucosides and α-galactosides.9 Neighbor-
ing group participation by the chiral auxiliary leads to a quasi-
stable anomeric sulfonium ion (Figure 1), which, due to steric
and electronic factors, is formed as a trans-decalin ring system.
Subsequent SN2-like displacement of the sulfonium ion then
leads to the stereoselective formation of α-glycosides.10,11
Although this methodology is highly stereoselective in many
cases, the stereoselectivity depends on the protecting groups
on the glycosyl donor and the structure of the auxiliary.10,12−20
Since the intermediate β-sulfonium ion is in rapid equilibrium
with the oxocarbenium ion, its formation alone is not a
guarantee for α-selective glycosylation since it may not be a
reactive intermediate in the glycosylation mecha-
nism.8,13,15,21,22 In addition, the preparation of glycosyl donors
equipped with a C-2 auxiliary is still labor intensive.
Herein we report a simple method to prepare anomeric β-
sulfonium ions from the corresponding β-thioglycosides via an
intramolecular alkylation reaction. Thioglycoside precursors
equipped with a C-2 2-hydroxyethyl group were prepared
using a straightforward three-step procedure starting from
commercially available glycal precursors. Triﬂation of the 2-
hydroxyethyl group led to intramolecular β-sulfonium ion
formation and subsequent glycosylation. The inﬂuence of the
thiophenyl substituent and the nature of the protecting groups
on the stereochemical outcome of the reaction were
investigated. The results reveal a systematic trend of increasing
α-selectivity with an increase in electron density on the
sulfonium ion and decrease in electron density on the
oxocarbenium ion. Hence, the most α-selective couplings
were achieved with a 2,4,6-trimethoxy thiophenyl group and
2,4-dichloro benzyl-protecting groups. The preactivation of the
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Figure 1. Retrosynthetic routes toward cyclic β-sulfonium ions.
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glycosyl donor allowed for the use of thioglycoside acceptors
opening the possibility for iterative thioglycoside couplings.
Glycosyl donors equipped with a 2-hydroxyethyl group at C-
2 were prepared from benzyl-protected glucal and galactal.
Oxidation of these glycals with oxone in acetone led to the
formation of the α-1,2-anhydro sugars, which were reacted
directly with thiophenol derivatives and ZnCl2 to yield the
corresponding β-thioglycosides as the main product in
moderate to good yields (Table 1).23 To investigate the eﬀect
of the thiophenyl group on the stereoselectivity, thiophenol, 4-
methoxy-thiophenol (PMP), 2,6-dimethoxy thiophenol
(DMP), and 2,4,6-trimethoxy thiophenol (TMP) were used,
yielding the corresponding thiogluco- and galactosides (Table
1, entries 1−8).24 Next, the C-2 2-hydroxyethyl group was
installed using THP-protected bromoethanol and NaH
followed by THP removal catalyzed by p-TsOH.
Next, we investigated the possibility to perform glycosyla-
tions with 7b−14b by intramolecular alkylation of the
thioglycoside to form intermediate β-sulfonium ions. To this
end, 7b−14b were reacted with Tf2O and 2,6-ditertbutyl-4-
methyl-pyridine (DTBMP) in DCM at −40 °C, and the
reactions were allowed to warm to 0 °C. Subsequent addition
of glycosyl acceptor 21 (−78 °C to rt) led to the formation of
disaccharides 22−29 in moderate to good yields (Table 2,
entries 1−8). A clear trend of increasing α-stereoselectivity was
observed with an increasing electron-donating character of the
aryl group in both the gluco and galacto series. The galacto
series was more α-selective than the gluco series, consistent
with earlier ﬁndings.22
However, the stereoselectivity of the TMP donor 10b was
considerably lower (α/β = 4/1) than expected based on an
earlier report (α-only).14 To investigate if the reaction indeed
proceeds via a β-sulfonium ion, we performed low-temperature
NMR studies. Glycosyl donor 10b was reacted with Tf2O and
DTBMP in CD2Cl2 at −78 °C (Figure 2). Upon warming to
−20 °C, a highly pure β-sulfonium ion was formed via
intramolecular alkylation (Figure 2C,D). This result does
therefore not explain the discrepancy in stereoselectivity. Since
our activation method is diﬀerent, we reproduced the reported
experiment (Supporting Information). In our hands, this
reaction gave the same α/β = 4/1 ratio as obtained with our
new coupling protocol (Table 2, entry 4).
To further improve the α-selectivity, we turned our attention
to the protecting groups. It is known that more electron-
withdrawing protecting groups improve the α-selectivity of
glycosylation proceeding via β-sulfonium ions.11,16 To
Table 1. Two-Step Synthesis of Glycosyl Donors 7b−18b
entry compound type R Ar
7a−18a
yield (%)a
7b−18b
yield (%)b
1 7 Glc Bn Ph 37 81
2 8 Glc Bn PMP 47 70
3 9 Glc Bn DMP 39 81
4 10 Glc Bn TMP 76 83
5 11 Gal Bn Ph 64 20
6 12 Gal Bn PMP 26 69
7 13 Gal Bn DMP 55 66
8 14 Gal Bn TMP 59 41
9 15 Glc CBn TMP 61 82
10 16 Glc 2,4-DCBn TMP 50 72
11 17 Gal CBn TMP 60 85
12 18 Gal 2,4-DCBn TMP 50 74
aIsolated yields of the β-thioglycoside products. bIsolated yield over
two steps.
Table 2. Glycosylation Results of Compounds 7b−20b
entry type donor Ar R α/βa
yield
(%) product
1 Glc 7b Ph Bn 2.5/1 71 22
2 Glc 8b PMP Bn 2.5/1 62 23
3 Glc 9b DMP Bn 3.5/1 83 24
4 Glc 10b TMP Bn 4/1 76 25
5 Gal 11b Ph Bn 3/1 55 26
6 Gal 12b PMP Bn 3/1 36 27
7 Gal 13b DMP Bn 6/1 37 28
8 Gal 14b TMP Bn 7/1 59 29
9 Glc 15b TMP CBn 5/1 75 30
10 Glc 19b TMP CNBn 7.5/1 65 31
11 Glc 16b TMP 2,4-DCBn 9/1 81 32
12 Gal 17b TMP CBn 9/1 33 33
13 Gal 20b TMP CNBn 12.5/1 87 34
14 Gal 18b TMP 2,4-DCBn 13/1 68 35
aα/β ratios were determined using NMR spectroscopy of the crude
reaction mixture after extraction.25,26
Figure 2. Low-temperature NMR spectra of the sulfonium ion
derived from 10b. (A) 1H NMR spectrum of 10b at −78 °C in
CD2Cl2. (B)
1H NMR of 10b at −78 °C after the addition of Tf2O.
(C) 1H NMR at −20 °C. (D) 1H NMR at −20 °C after 30 min.
Complete conversion to sulfonium ion 10c is observed.
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investigate the role in our system, benzyl ethers with
increasingly electron-withdrawing substituents were installed.27
Benzyl ethers were used to minimize alternate reaction
pathways such as neighboring group participation that may
arise when using ester-protecting groups. To this end, glycal
precursors were prepared equipped with benzyl (Bn), p-
chlorobenzyl (CBn) and 2,4-dichlorobenzyl (2,4-DCBn)
ethers (Supporting Information). Subsequent oxidation and
reaction with 2,4,6-trimethoxy thiophenol aﬀorded TMP
thioglycosides 15a−18a (Table 1, entries 9−12). Finally,
installation of the 2-hydroxyethyl group as before yielded
glycosyl donors 15b−18b. In addition, the CBn protected
donors 15b and 17b were converted to the p-cyanobenzyl
(CNBn) derivatives (19b and 20b) using a recently reported
procedure.28
Next, we evaluated the glycosylation properties of 15b−20b
(Table 2, entries 9−14) using the aforementioned glyco-
sylation protocol. As expected, a clear trend was observed with
increasingly electron-withdrawing benzyl ethers with 2,4-
DCBn giving the most α-selective results. The optimal
combination for α-selective glycosylation is therefore the
electron-rich 2,4,6-trimethylthiophenyl group and the electron-
withdrawing 2,4-DCBn group to protect the C-3, C-4, and C-6
positions. Using this optimal combination for both glucose
(16b) and galactose (18b), the glycosyl acceptor scope was
investigated. To this end, two additional glycosyl acceptors 36
and 37 were evaluated (Table 3).
From the results, it is clear that the α-stereoselecitivity is
maintained across diﬀerent glycosyl acceptors. It is noteworthy
that thioglycoside acceptors could be used (37) to perform
chemoselective coupling of thioglycoside donors 16b and 18b.
Hence, the developed method is amendable to iterative
thioglycoside couplings.
Finally, the importance of the β-sulfonium ion as a reactive
intermediate was investigated using a number of control
experiments (Table 4). The eﬀect of electron-withdrawing
protecting groups on the stereoselectivity can be explained by
widening of the energy gap between the oxocarbenium and
sulfonium ion. The inductive eﬀect of the protecting groups is
more remote from the sulfonium ion than the oxocarbenium
ion and hence aﬀect the latter intermediate to a greater extend.
We prepared glycosyl donors containing a C-2 nonparticipat-
ing group (Bn or Pr) and Bn or 2,4-DCBn groups at the
remaining sites. Using these donors, a preactivation method
was not possible at the typically used glycosylation temperature
(0 °C), and hence, we resorted to premix conditions (NIS,
TfOH). From the results, it is clear that in both the C-2 OBn-
and OPr-protected donors the α-selectivity increased with
increased electron-withdrawing protecting groups (Table 4,
entries 1−4).
This suggests that the background reaction taking place in
the sulfonium ion reactions also becomes more α-selective. It is
clear that the sulfonium ion intermediate is important for α-
selectivity since these reactions are considerably more selective
Table 3. Glycosyl Acceptor Scope of Glycosyl Donors 16b and 18b
aα/β ratios were determined using NMR spectroscopy of the crude reaction mixture after extraction.25,26
Table 4. Control Experiments To Evaluate the Contribution of the β-Sulfonium Ion Intermediate in the Reaction Mechanisma
entry donor R R1 (method) α/β
b yield (%) product
1 42 Bn Bn (A) 1.4/1 68 50
2 43 2,4-DCBn Bn (A) 4/1 57 51
3 44 Bn Propyl (A) 1.2/1 65 52
4 45 2,4-DCBn Propyl (A) 3/1 51 53
5 46 Bn (CH2)3OH (B) 2/1 71 54
6 47 2,4-DCBn (CH2)3OH (B) 2.5/1 49 55
7 48 Bn Ac (A) >1/20 83 56
8 49 2,4-DCBn Ac (A) >1/20 60 57
aMethod A: 21, NIS, TfOH, DCM, 0 °C. Method B: (1) Tf2O, DTBMP, DCM, −40 to 0 °C; (2) 21, −40 °C to rt. bα/β ratios were determined
using NMR spectroscopy of the crude reaction mixture after extraction.25,26
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(α/β = 9/1 vs 4/1). This is highlighted by the fact that
increasing the ring size by the use of a C-2 3-hydroxypropyl
group led to a complete loss of stereoselectivity regardless of
the protecting group used (Table 4, entries 5 and 6). To
demonstrate that late-stage switching to β-selective couplings is
possible and is not aﬀected by the protecting group pattern,
compound 10a was acetylated and coupled using NIS/TfOH
(Table 4, entries 7− and 8). Using this synthetic route, late-
stage introduction of the C-2 functionality allows the synthesis
of a highly α- (10b) and β-selective (49) glycosyl donor in a
one-step procedure starting from a general building block
(10a). Finally, deprotection of the auxiliary of 32 was achieved
using a previously reported procedure involving methylation of
the thioether followed by elimination under basic conditions to
aﬀord the corresponding C-2 OH compound (58).14
In conclusion, a novel and versatile methodology for the
formation of α-glycosidic linkages was developed. Thioglyco-
sides were activated to form β-sulfonium ions via an
intramolecular alkylation reaction. The reactivity and selectiv-
ity of the β-sulfonium ions was modulated by the systematic
variation of the thioglycoside substituent and the electronic
nature of the protecting groups. An electron-rich thioglycoside
with electron-withdrawing protecting groups proved to be the
optimal combination. Consistent α-selectivity was observed for
a number of glycosyl acceptors. In addition, chemoselective
coupling of glycosyl donor thioglyocosides to thioglycoside
acceptors is possible. Mechanistic studies indicate the electron-
withdrawing protecting groups also improve the α-selectivity of
C-2 benzyl-protected donors in addition to the sulfonium ion.
Late-stage modulation of donor selectivity is possible by
introduction of the 2-hydroxy ethyl substituent for α-selectivity
or the installation of a C-2 acetyl group for β-selective
couplings.
■ EXPERIMENTAL SECTION
General Procedures. 1H and 13C NMR spectra were recorded on
a Bruker 400 or 500 MHz spectrometer. Chemical shifts are reported
in parts per million (ppm) relative to tetramethylsilane (TMS), or
residual solvents as the internal standard. NMR data is presented as
follows: chemical shift, multiplicity (s = singlet, d = doublet, t =
triplet, dd = doublet of doublets, m = multiplet and/or multiple
resonances), coupling constant (J) in hertz (Hz), integration. All
NMR signals were assigned on the basis of 1H NMR, 13C NMR,
COSY, HSQC, and TOCSY experiments. NMR data is presented for
the major anomer. Mass spectra were recorded on an JEOL AccuTOF
CS JMS-T100CS mass spectrometer. Optical rotations were measured
at 589 nm using a PerkinElmer Polarimeter Model 241 MC.
Automatic ﬂash column chromatography was performed using
Biotage Isolera Spektra One, using SNAP cartridges (Biotage, 30−
100 μm, 60 Å), 10−50 g. TLC analysis was conducted on silica gel
F254 (Merck KGaA) with detection by UV absorption (254 nm)
where applicable and by spraying with 10% sulfuric acid in methanol
followed by charring at ≈300 °C. DCM, THF, and toluene were
freshly distilled. Molecular sieves (4 Å) were ﬂame-activated under a
vacuum prior to use. All inert reactions were carried out under an
argon atmosphere using ﬂame-dried ﬂasks.
General Procedure A. D-Glucal or D-galactal was dissolved in dry
DMF (0.2 M) under an inert atmosphere and cooled to 0 °C. NaH (8
equiv; 60% dispersion in mineral oil) was added, and the reaction
mixture was stirred for 30 min, after which the corresponding
benzylating agent (5 equiv) was added. The reaction was stirred for
16 h at ambient temperature, after which it was quenched with
MeOH. The mixture was concentrated under reduced pressure and
taken up in DCM (100 mL) and water (100 mL). The aqueous layer
was extracted with DCM (2 × 100 mL). The combined organic layers
were washed with brine (100 mL), dried (MgSO4), ﬁltered, and
concentrated under reduced pressure to yield the crude product.
General Procedure B. To a cooled (0 °C) solution of a benzylated
glycal (2.4 mmol) in DCM (10 mL) were added acetone (1 mL) and
saturated aqueous NaHCO3 (17 mL). The mixture was stirred
vigorously, and a solution of oxone (4.8 mmol) in H2O (6 mL) was
added dropwise over 15 min. The mixture was stirred vigorously at 0
°C for 30 min and then at rt until TLC indicated consumption of the
starting material. The organic phase was separated, and the aqueous
phase was extracted with DCM (2 × 10 mL). The combined organic
phases were dried (Na2SO4) and concentrated in vacuo. The crude
mixture was dissolved in dry DCM (23 mL). MS (4 Å) and the
corresponding thiol (3.6 mmol) were added under an inert
atmosphere. The mixture was cooled to −78 °C and stirred for 15
min. ZnCl2 (1 M in Et2O) (0.24 mmol) was added, and the mixture
was stirred overnight while slowly warmed up to rt. The reaction was
quenched with TEA and puriﬁed with silica gel ﬂash column
chromatography to obtain the pure product.
General Procedure C. An anomeric thioether with a free 2-OH
(7a−19a) was dissolved in dry DMF (0.1 M) and cooled to 0 °C.
NaH (4 equiv; 60% dispersion in mineral oil) was added, and the
mixture was stirred at 0 °C for 15 min, after which the appropriate
auxiliary (Br(CH2)2OTHP or Br(CH2)3OTHP) was added (4 equiv).
The reaction was stirred for 16 h at ambient temperature, after which
it was quenched with MeOH. The reaction mixture was concentrated
under reduced pressure and was taken up in MeOH (25 mL). p-
TsOH was added until a pH of 2 was reached. The reaction was
stirred for 4 h and subsequently concentrated under reduced pressure.
The residue was dissolved in EtOAc (20 mL) and washed with water
(3 × 20 mL). The organic layer was dried (MgSO4), ﬁltered, and
concentrated under reduced pressure to yield the crude product.
General Procedure D. Thioglucosides 10a or 16a were dissolved in
dry DMF (0.1 M), and the mixture was cooled to 0 °C. NaH (4
equiv; 60% dispersion in mineral oil) was added, and the mixture was
stirred at 0 °C for 15 min, after which benzyl bromide or propyl
bromide was added (4 equiv). The reaction was stirred for 16 h at
ambient temperature, after which it was quenched with MeOH. The
reaction mixture was concentrated under reduced pressure, and the
residue was taken up in EtOAc (20 mL). The organic layer was
washed with water (3 × 20 mL), brine (20 mL), dried (MgSO4),
ﬁltered, and concentrated under reduced pressure, yielding the crude
product.
General Glycosylation Procedure E. The corresponding glycosyl
donor (1 equiv) and DTBMP (4 equiv) were dissolved in dry DCM
(0.05 M). MS (4 Å) were added, and the mixture was stirred at −40
°C for 15 min. Tf2O (1.5 equiv) was added, and the mixture was
allowed to slowly warm up to 0 °C and stirred at 0 °C for 30 min.
When TLC analysis indicated complete consumption of the triﬂated
intermediate, the mixture was cooled down to −78 °C and the
appropriate acceptor (1.5 equiv) was added. The reaction was left to
warm up to rt in 16 h and was subsequently taken up in EtOAc (20
mL) and ﬁltered. The ﬁltrate was washed with aq Na2S2O3 (20 mL,
10%), brine (20 mL), dried (MgSO4), ﬁltered, and concentrated
under reduced pressure to yield the crude product.
General Glycosylation Procedure F. The corresponding glycosyl
donor (1 equiv) and acceptor (2 equiv) were dissolved in dry DCM
(0.05 M). MS (4 Å) were added, and the mixture was cooled to −5
°C. NIS (1.1 equiv) and TfOH (0.2 equiv) were added, and the
reaction was stirred for 2 h. The reaction was quenched with Et3N
and taken up in EtOAc (20 mL) and ﬁltered. The ﬁltrate was washed
with aq Na2S2O3 (20 mL, 10%), brine (20 mL), dried (MgSO4),
ﬁltered, and concentrated under reduced pressure to yield the crude
product.
3,4,6-Tri-O-benzyl-D-glucal (1). Using general procedure A starting
from D-glucal (5.13 g, 35.1 mmol) using benzyl bromide, the crude
product was puriﬁed by silica gel ﬂash column chromatography (0%
to 30% EtOAc in n-heptane), aﬀording 1 (13.3 g, 91%). TLC
(EtOAc/n-heptane, 30/70 v/v): Rf = 0.55.
1H NMR (500 MHz,
CDCl3): δ 7.37−7.21 (m, 15H), 6.42 (dd, J = 6.1, 1.3 Hz, 1H, H-1),
4.87 (dd, J = 6.2, 2.7 Hz, 1H, H-2), 4.83 (d, J = 11.3 Hz, 1H), 4.66−
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4.61 (m, 2H), 4.61−4.53 (m, 3H), 4.21 (ddd, J = 6.2, 2.7, 1.3 Hz, 1H,
H-3), 4.06 (ddd, J = 8.3, 5.1, 2.9 Hz, 1H, H-5), 3.86 (dd, J = 8.7, 6.2
Hz, 1H, H-4), 3.83−3.72 (m, 2H, H-6). 13C{1H} NMR (126 MHz,
CDCl3): δ 144.7 (C-1), 138.3, 138.2, 138.0, 128.5, 128.4, 128.3,
127.9, 127.8, 127.7, 127.6, 99.9 (C-2), 76.7 (C-5), 75.7 (C-3), 74.4
(C-4), 73.8, 73.51, 70.45, 68.5 (C-6).
3,4,6-Tri-O-(4-chlorobenzyl)-D-glucal (2). Using general procedure
A starting from D-glucal (2.0 g, 13.7 mmol) using 4-chlorobenzyl
chloride (11.0 g, 68 mmol), the crude product was puriﬁed by silica
gel ﬂash column chromatography (0% to 20% EtOAc in n-heptane),
yielding 2 (6.23 g, 88%). TLC (EtOAc/n-heptane, 40/60 v/v): Rf =
0.76. 1H NMR (500 MHz, CDCl3): δ 7.33−7.19 (m, 11H), 7.16−
7.10 (m, 2H), 6.41 (dd, J = 6.1, 1.4 Hz, 1H, H-1), 4.85 (dd, J = 6.2,
2.6 Hz, 1H, H-2), 4.75 (d, J = 11.6 Hz, 1H), 4.58 (d, J = 11.8 Hz,
2H), 4.54 (d, J = 12.2 Hz, 1H), 4.50−4.45 (m, 2H), 4.18 (ddd, J =
6.3, 2.6, 1.4 Hz, 1H, H-3), 4.01 (ddd, J = 8.8, 4.8, 2.7 Hz, 1H, H-5),
3.81 (dd, J = 8.9, 6.3 Hz, 1H, H-4), 3.77 (dd, J = 10.7, 4.8 Hz, 1H, H-
6a), 3.72 (dd, J = 10.8, 2.7 Hz, 1H, H-6b). 13C{1H} NMR (126 MHz,
CDCl3): δ 144.9 (C-1), 136.8, 136.6, 136.4, 133.54, 133.49, 133.46,
129.04, 129.01, 128.96, 128.60, 128.57, 99.7 (C-2), 76.7 (C-5), 76.0
(C-3), 74.5 (C-4), 72.9, 72.7, 69.6, 68.5 (C-6). HRMS (ESI-TOF)
(m/z): [M + Na]+ calcd for C27H25Cl3O4Na, 541.0716; found,
541.0707.
3,4,6-Tri-O-(2,4-dichlorobenzyl)-D-glucal (3). Using general pro-
cedure A starting from D-glucal (1.7 g, 11.6 mmol) using 2,4-dichloro-
1-(chloromethyl)benzene, the crude product was puriﬁed by silica gel
ﬂash column chromatography (0% to 20% EtOAc in n-heptane),
yielding 3 (6.39 g, 90%). TLC (EtOAc/n-heptane, 40/60 v/v): Rf =
0.76. 1H NMR (500 MHz, CDCl3): δ 7.49−7.26 (m, 9H), 7.25−7.15
(m, 3H), 6.45 (dd, J = 6.1, 1.4 Hz, 1H, H-1), 4.92 (dd, J = 6.2, 2.5 Hz,
1H, H-2), 4.89 (d, J = 12.7 Hz, 1H), 4.73 (d, J = 12.8 Hz, 1H), 4.71−
4.66 (m, 1H), 4.63 (d, J = 13.4 Hz, 1H), 4.56 (dd, J = 13.1, 3.7 Hz,
2H), 4.28 (ddd, J = 6.4, 2.6, 1.4 Hz, 1H, H-3), 4.07 (ddd, J = 9.1, 4.5,
2.6 Hz, 1H, H-5), 3.95−3.87 (m, 2H, H-4, H-6a), 3.82 (dd, J = 10.7,
2.7 Hz, 1H, H-6b). 13C{1H} NMR (126 MHz, CDCl3): δ 145.0 (C-
1), 134.53, 134.50, 134.3, 133.94, 133.87, 133.8, 133.36, 133.33,
133.2, 130.0, 129.9, 129.8, 129.7, 129.6, 129.2, 129.07, 129.05, 129.01,
127.2, 127.10, 127.07, 127.03, 99.6 (C-2), 76.7 (C-3), 76.6 (C-5),
74.6 (C-4), 71.0, 70.2, 69.9, 69.3, 69.0 (C-6), 67.0. HRMS (ESI-
TOF) (m/z): [M + Na]+ calcd for C27H22Cl6O4Na, 642.9547; found,
642.9545.
3,4,6-Tri-O-benzyl-β-D-galactal (4). Using general procedure A
starting from D-galactal (5.00 g, 34.2 mmol) using benzyl bromide,
silica gel ﬂash column chromatography (0% to 30% EtOAc in n-
heptane) aﬀorded 4 (12.39 g, 29.8 mmol, 87%). TLC (EtOAc/n-
heptane, 50/50 v/v): Rf = 0.74.
1H NMR (500 MHz, CDCl3): δ
7.37−7.22 (m, 15H), 6.36 (dd, J = 6.2, 1.4 Hz (H-1)), 4.85 (ddd, J =
8.5, 6.6, 4.1 Hz, 1H, H-2), 4.67−4.58 (m, 3H), 4.50 (d, J = 11.9 Hz,
1H), 4.42 (d, J = 11.9 Hz, 1H), 4.21−4.15 (m, H-3, H-5), 3.96−3.92
(m, H-4), 3.78 (dd, J = 10.1, 7.2 Hz, H-6a), 3.65 (dd, J = 10.2, 5.1 Hz,
H-6b). 13C{1H} NMR (126 MHz, CDCl3): δ 144.2 (C-1), 138.5,
138.4, 138.0, 128.4, 128.3, 128.2, 127.9, 127.7, 127.6, 127.5, 100.0 (C-
2), 75.7 (C-5), 73.44, 73.35, 71.3 (H-4), 70.9, 70.8 (C-3), 68.5 (H-6).
HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for C27H28O4Na,
439.1885; found, 439.1877.
3,4,6-Tri-O-(4-chlorobenzyl)-β-D-galactal (5). Using general pro-
cedure A starting from D-galactal (72 mg, 0.492 mmol) and 4-
chlorobenzyl bromide, silica gel ﬂash column chromatography (0% to
30% EtOAc in n-heptane) aﬀorded 5 (0.12 g, 0.231 mmol, 47%).
TLC (EtOAc/n-heptane, 30/70 v/v): Rf = 0.37.
1H NMR (500 MHz,
CDCl3): δ 7.25 (m, 12H), 6.36 (dd, J = 6.3, 1.4 Hz, H-1), 4.84 (ddd, J
= 6.3, 3.0, 1.2 Hz, H-2), 4.79 (d, J = 12.0 Hz, 1H), 4.61 (d, J = 12.1
Hz, 1H), 4.57 (d, J = 12.0 Hz, 1H), 4.53 (d, J = 12.1 Hz, 1H), 4.49
(d, J = 12.1 Hz, 1H), 4.39 (d, J = 12.1 Hz, 1H), 4.17 (m, H-3, H-5),
3.91 (m, H-4), 3.74 (dd, J = 10.1, 7.2 Hz, H-6a), 3.63 (dd, J = 10.1,
5.1 Hz, H-6b). 13C{1H} NMR (126 MHz, CDCl3): δ 144.3 (C-1),
136.8, 136.7, 136.4, 133.54, 133.52, 133.4, 132.6, 129.2, 129.1, 128.7,
128.58, 128.56, 128.50, 99.6 (C-2), 75.5 (C-5), 72.6, 72.5, 71.6 (C-4),
70.8 (C-3), 70.2, 68.2 (C-6). HRMS (ESI-TOF)(m/z): [M + Na]+
calcd for C27H25Cl3O4Na, 541.0716; found, 541.0709.
3,4,6-Tri-O-(2,4-dichlorobenzyl)-β-D-galactal (6). Using general
procedure A starting from D-galactal (2.0 g, 13.7 mmol) and 2,4-
dichlorobenzyl chloride, silica gel ﬂash column chromatography (0%
to 30% EtOAc in n-heptane) aﬀorded 6 (3.88 g, 6.29 mmol, 46%).
TLC (EtOAc/n-heptane, 30/70 v/v): Rf = 0.60.
1H NMR (500 MHz,
CDCl3): δ 7.46−7.15 (m, 9H), 6.41 (dd, J = 6.2, 1.3 Hz, H-1), 4.93−
4.87 (m, 1H, H-2), 4.72 (d, J = 6.6 Hz, 1H), 4.69 (d, J = 6.6 Hz, 1H),
4.66−4.58 (m, 2H), 4.51 (d, J = 13.0 Hz, 1H), 4.32−4.26 (m, H-3, H-
5), 4.08−4.04 (m, H-4), 3.87−3.76 (m, H-6a, H-6b). 13C{1H} NMR
(126 MHz, CDCl3): δ 144.4 (C-1), 134.70, 134.65, 134.2, 134.0,
133.8, 133.6, 133.1, 133.0, 130.07, 130.01, 129.6, 129.2, 129.0, 128.9,
127.11, 127.07, 99.5 (C-2), 75.3 (C-5), 72.4 (H-4), 71.6 (C-3), 70.0,
69.9, 68.6 (C-6), 67.8. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd
for C27H22Cl6O4Na, 642.9547; found, 642.9545.
3,4,6-Tri-O-benzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl-α-
D-glycopyranosyl)trichloroacetimidate (10d). Glucosyl donor 10b
(1 equiv) and DTBMP (4 equiv) were dissolved in dry DCM (2 mL).
MS (4 Å) were added under an inert atmosphere, and the mixture was
stirred at −40 °C for 15 min. Tf2O (1.5 equiv) was added, and the
mixture was allowed to slowly warm up to 0 °C and stirred at 0 °C for
30 min. When TLC analysis indicated complete consumption of the
triﬂated intermediate, the mixture was quenched with H2O, taken up
in EtOAc (20 mL), and ﬁltered. The ﬁltrate was washed with aq
Na2S2O3 (20 mL, 10%) and brine (20 mL), dried (MgSO4), ﬁltered,
and concentrated under reduced pressure. The crude product was
puriﬁed using silica gel ﬂash column chromatography (20% to 60%
EtOAc in n-heptane), yielding the lactol (98 mg, 0.16 mmol, 63%).
The lactol (1 equiv) was dissolved in dry DCM (0.015 M).
Trichloroacetonitrile (10 equiv) and DBU (4 equiv) were added, and
the mixture was stirred at 0 °C. After 7 h, TLC showed the formation
of a major product. The reaction was concentrated in vacuo and
puriﬁed using silica gel ﬂash column chromatography (petroleum
ether/EtOAc 20%, with 1% TEA) to aﬀord 10d (51 mg, 84%).
Spectral data were consistent with literature values of the reported
compound by Singh et al.14 Using 10d, a glycosylation reaction under
identical conditions was performed as reported by Singh et al. In our
hands, this experiment gave a 4/1 α/β ratio. This is consistent with
the results obtained with 10b but diﬀerent from the report by Singh et
al.
Phenyl 3,4,6-Tri-O-benzyl-1-thio-β-D-glucopyranoside (7a).
Using general procedure B starting from 1(0.81 g, 1.52 mmol) and
thiophenol, silica gel ﬂash column chromatography (0% to 30%
EtOAc in n-heptane) aﬀorded 7a (0.30 g, 0.56 mmol, 37%). TLC
(EtOAc/n-heptane, 30/70 v/v): Rf = 0.4.
1H NMR (500 MHz,
CDCl3): δ 7.60−7.52 (m, 2H), 7.37−7.16 (m, 18H), 4.91 (d, J = 11.2
Hz, 1H), 4.86−4.80 (m, 2H), 4.61 (d, J = 12.1 Hz, 1H), 4.57 (d, J =
10.9 Hz, 1H), 4.54 (d, J = 12.0 Hz, 1H), 4.50 (d, J = 9.6 Hz, 1H (H-
1)), 3.79 (dd, J = 10.9, 2.0 Hz, 1H (H-6)), 3.73 (dd, J = 11.0, 4.5 Hz,
1H (H-6)), 3.64−3.46 (m, 4H (H-2, H-3, H-4, H-5)), 2.45 (s, 1H).
13C{1H} NMR (126 MHz, CDCl3): δ 138.4, 138.2, 138.0, 132.8,
131.7, 128.9, 128.5, 128.4, 128.3, 128.0, 127.92, 127.89, 127.7, 127.6,
127.5, 88.0 (C-1), 85.9 (C-3), 79.4 (C-5), 77.3 (C-4), 75.3, 75.0,
73.4, 72.5 (C-2), 68.9 (C-6). HRMS (ESI-TOF) (m/z): [M + Na]+
calcd for C33H34O5SNa, 565.2025; found, 565.2022
4-Methoxyphenyl 3,4,6-Tri-O-benzyl-1-thio-β-D-glucopyranoside
(8a). Using general procedure B starting from 1 (0.185 g, 0.446
mmol) and 4-methoxythiophenol, silica gel ﬂash column chromatog-
raphy (0% to 30% EtOAc in n-heptane) aﬀorded 8a (0.12 g, 0.21
mmol, 47%). TLC (EtOAc/n-heptane, 40/60 v/v): Rf = 0.7.
1H NMR
(500 MHz, CDCl3): δ 7.50 (d, J = 8.8 Hz, 1H), 7.38−7.15 (m, 14H),
6.76 (d, J = 8.8 Hz, 1H), 4.93−4.78 (m, 3H), 4.64−4.51 (m, 3H),
4.36 (d, J = 9.6 Hz, 1H (H-1)), 3.80−3.72 (m, 5H (H-6, H-6,
OMe)), 3.61−3.53 (m, 2H (H-3, H-4)), 3.50 (ddd, J = 7.4, 4.3, 2.1
Hz, 1H (H-5)), 3.40 (dd, J = 9.6, 8.4 Hz, 1H (H-2)), 2.41 (s, 1H).
13C{1H} NMR (126 MHz, CDCl3): δ 160.2, 138.5, 138.4, 138.1,
136.0, 128.5, 128.43, 128.35, 128.01, 127.98, 127.8, 127.64, 127.56,
121.1, 114.5, 88.0 (C-1), 85.9 (C-3), 79.4 (C-5), 77.4 (C-4), 75.3,
75.1, 73.5, 72.3 (C-2), 69.0 (C-6), 55.3. HRMS (ESI-TOF) (m/z):
[M + Na]+ calcd for C34H36O6SNa, 595.2130; found, 595.2134
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2,6-Dimethoxyphenyl 3,4,6-Tri-O-benzyl-1-thio-β-D-glucopyra-
noside (9a). Using general procedure B starting from 1 (0.779 g,
1.87 mmol) and 2,6-dimethoxythiophenol, silica gel ﬂash column
chromatography (0% to 30% EtOAc in n-heptane) aﬀorded 9a (0.44
g, 0.731 mmol, 39%). TLC (EtOAc/n-heptane, 40/60 v/v): Rf = 0.6.
1H NMR (500 MHz, CDCl3): δ 7.45−7.08 (m, 16H), 6.56 (d, J = 8.4
Hz, 2H), 5.04 (d, J = 11.1 Hz, 1H), 4.79 (dd, J = 11.0, 1.7 Hz, 2H),
4.57−4.50 (m, 2H), 4.46 (d, J = 11.7 Hz, 1H), 4.29 (d, J = 9.6 Hz,
1H, H-1), 3.83 (m, 7H), 3.79 (d, J = 2.7 Hz, 2H (H-6, H-6)), 3.61 (t,
J = 8.7 Hz, 1H (H-3)), 3.53 (dd, J = 9.7, 8.7 Hz, 1H (H-4)), 3.46 (dt,
J = 9.7, 2.7 Hz, 1H (H-5)), 3.32 (ddd, J = 9.5, 8.6, 1.9 Hz, 1H (H-2)).
13C{1H} NMR (126 MHz, CDCl3): δ 162.2, 138.8, 138.4, 138.3,
131.6, 128.27, 128.26, 128.2, 127.9, 127.8, 127.7, 127.6, 127.5, 127.4,
105.0, 104.6, 88.4 (C-1), 85.6 (C-3), 80.0 (C-5), 76.9 (C-4), 75.2,
75.0, 73.6, 73.5 (C-2), 69.1 (C-6), 56.4. HRMS (ESI-TOF) (m/z):
[M + Na]+ calcd for C35H38O7SNa, 625.2236; found, 625.2223
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-benzyl-1-thio-β-D-glucopyr-
anoside (10a). Using general procedure B starting from 1 (0.303 g,
0.729 mmol) and 2,4,6-trimethoxythiophenol, the crude product was
puriﬁed by silica gel ﬂash column chromatography (10% to 40%
EtOAc in n-heptane), yielding 10a (0.35 g, 0.554 mmol, 76%). TLC
(EtOAc/n-heptane, 40/60 v/v): Rf = 0.41.
1H NMR (500 MHz,
CDCl3): δ 7.40−7.13 (m, 15H), 6.11 (s, 2H), 5.04 (d, J = 11.0 Hz,
1H), 4.79 (dd, J = 11.0, 2.6 Hz, 2H), 4.54 (dd, J = 11.2, 7.6 Hz, 2H),
4.45 (d, J = 11.6 Hz, 1H), 4.20 (d, J = 9.4 Hz, 1H, H-1), 3.84−3.77
(m, 11H, H-2, H-6), 3.61 (t, J = 8.8 Hz, 1H, H-3), 3.54 (t, J = 9.3 Hz,
1H, H-4), 3.46 (ddd, J = 9.7, 3.2, 2.0 Hz, 1H, H-5), 3.28 (ddt, J = 9.5,
8.7, 2.5 Hz, 1H, H-2). 13C{1H} NMR (126 MHz, CDCl3): δ 163.2,
163.0, 139.0, 138.6, 138.4, 128.3, 128.2, 128.0, 127.9, 127.7, 127.6,
127.49, 127.45, 96.2, 91.5, 88.5 (C-1), 85.6 (C-3), 80.0 (C-5), 76.9
(C-4), 75.2, 75.1, 73.7, 73.2 (C-2), 73.1, 69.2 (C-6), 56.4, 55.4.
HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for C36H40O8SNa,
655.2342; found, 655.2339.
Phenyl 3,4,6-Tri-O-benzyl-2-O-(2-hydroxyethyl)-1-thio-β-D-glu-
copyranoside (7b). Using general procedure C starting from 7a
(0.137 g, 0.253 mmol), silica gel ﬂash column chromatography (0% to
30% EtOAc in n-heptane) aﬀorded 7b (0.12 g, 0.205 mmol, 81%).
TLC (EtOAc/n-heptane, 30/70 v/v): Rf = 0.4.
1H NMR (500 MHz,
CDCl3): δ 7.61−7.54 (m, 2H), 7.38−7.15 (m, 17H), 4.91 (d, J = 10.9
Hz, 1H), 4.85 (d, J = 10.9 Hz, 1H), 4.80 (d, J = 10.8 Hz, 1H), 4.64−
4.56 (m, 2H), 4.57 (d, J = 9.8 Hz, 1H (H-1)), 4.54 (d, J = 12.0 Hz,
1H), 3.89 (ddd, J = 10.7, 5.8, 3.0 Hz, 1H), 3.83 (ddd, J = 10.7, 6.0, 3.0
Hz, 1H), 3.78 (dd, J = 10.9, 2.0 Hz, 1H (H-6)), 3.72 (dd, J = 10.9, 4.5
Hz, 1H (H-6)), 3.70−3.61 (m, 4H (H-3, H-4)), 3.50 (ddt, J = 6.6,
4.6, 1.9 Hz, 1H (H-5)), 3.40−3.33 (m, 1H (H-2)), 2.72 (s, 1H).
13C{1H} NMR (126 MHz, CDCl3): δ 138.2, 137.9, 137.8, 133.2,
131.9, 128.9, 128.5, 128.4, 128.3, 127.9, 127.9, 127.8, 127.64, 127.59,
127.57, 87.5 (C-1), 86.6 (C-3), 80.6 (C-2), 79.1 (C-5), 77.9 (C-4),
77.3, 77.0, 76.8, 75.9, 75.0, 74.7, 73.4, 68.8 (C-6), 62.3. HRMS (ESI-
TOF) (m/z): [M + Na]+ calcd for C35H38O6SNa, 609.2287; found,
609.2275
4-Methoxyphenyl 3,4,6-Tri-O-benzyl-2-O-(2-hydroxyethyl)-1-
thio-β-D-glucopyranoside (8b). Using general procedure C starting
from 8a (0.172 g, 0.301 mmol), silica gel ﬂash column
chromatography (0% to 30% EtOAc in n-heptane) aﬀorded 8b
(0.13 g, 0.211 mmol, 70%). TLC (EtOAc/n-heptane, 40/60 v/v): Rf
= 0.4. 1H NMR (500 MHz, CDCl3): δ 7.46 (d, J = 8.9 Hz, 2H),
7.30−7.16 (m, 13H), 7.12 (dd, J = 7.5, 2.1 Hz, 2H), 6.67 (d, J = 8.8
Hz, 2H), 4.83 (d, J = 10.9 Hz, 1H), 4.76 (d, J = 10.9 Hz, 1H), 4.72
(d, J = 10.9 Hz, 1H), 4.57−4.42 (m, 4H), 4.36 (d, J = 9.7 Hz, 1H),
3.83 (ddd, J = 10.7, 5.4, 3.1 Hz, 1H), 3.76 (ddd, J = 10.7, 6.1, 3.1 Hz,
1H), 3.72−3.51 (m, 11H (H-3, H-4, H-6, H-6)), 3.38 (ddd, J = 9.5,
4.3, 1.9 Hz, 1H (H-5)), 3.22 (dd, J = 9.7, 8.6 Hz, 1H (H-2)), 2.72 (s,
1H). 13C{1H} NMR (126 MHz, CDCl3): δ 159.8, 138.2, 137.90,
137.85, 135.2, 128.5, 128.4, 128.3, 127.86, 127.84, 127.6, 127.5, 122.7,
114.4, 87.8 (C-1), 86.6 (C-3), 80.5 (C-2), 79.0 (C-5), 78.0 (C-4),
75.8, 75.0, 74.7, 73.4, 73.3, 68.9 (C-6), 62.3, 55.3. HRMS (ESI-TOF)
(m/z): [M + Na]+ calcd for C36H40O7SNa, 639.2392; found,
639.2382
2,6-Dimethoxyphenyl 3,4,6-Tri-O-benzyl-2-O-(2-hydroxyethyl)-
1-thio-β-D-glucopyranoside (9b). Using general procedure C starting
from 9a (0.184 g, 0.306 mmol), silica gel ﬂash column
chromatography (0% to 30% EtOAc in n-heptane) aﬀorded 9b
(0.16 g, 0.248 mmol, 81%). TLC (EtOAc/n-heptane, 40/60 v/v): Rf
= 0.30. 1H NMR (500 MHz, CDCl3): δ 7.37−7.21 (m, 14H), 7.17
(dd, J = 7.3, 2.2 Hz, 2H), 6.56 (d, J = 8.3 Hz, 2H), 4.87 (s, 2H), 4.79
(d, J = 10.8 Hz, 1H), 4.55 (d, J = 10.9 Hz, 1H), 4.53 (d, J = 10.0 Hz,
1H (H-1)), 4.49 (d, J = 11.9 Hz, 1H), 4.46 (d, J = 11.9 Hz, 1H), 4.05
(ddd, J = 10.9, 5.7, 2.5 Hz, 1H), 3.95 (ddd, J = 10.8, 6.7, 2.4 Hz, 1H),
3.84 (m, 7H), 3.75−3.67 (m, 2H (H-6)), 3.66−3.59 (m, 2H (H-3, H-
6)), 3.59−3.48 (m, 2H (H-4)), 3.43−3.32 (m, 2H (H-2, H-5)).
13C{1H} NMR (126 MHz, CDCl3): δ 161.0, 138.4, 138.2, 137.9,
130.4, 128.5, 128.4, 128.3, 127.93, 127.88, 127.82, 127.80, 127.5,
108.6, 104.3, 87.9 (C-1), 87.2 (C-3), 81.7 (C-2), 79.6 (C-5), 78.2 (C-
4), 75.8, 75.0, 74.9, 73.6, 69.4 (C-6), 61.9, 56.3. HRMS (ESI-TOF)
(m/z): [M + Na]+ calcd for C37H42O8SNa, 669.2498; found,
669.2495.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-benzyl-2-O-(2-hydroxyeth-
yl)-1-thio-β-D-glucopyranoside (10b). Using general procedure C
starting from 10a (330 mg, 0.55 mmol), silica gel ﬂash column
chromatography (30% to 60% EtOAc in n-heptane) aﬀorded 10b as a
white solid (0.294 g, 0.434 mmol, 83%). TLC (EtOAc/n-heptane, 40/
60 v/v): Rf = 0.21.
1H NMR (500 MHz, CDCl3): δ 7.46−7.11 (m,
18H), 6.12 (s, 2H), 4.87 (s, 2H), 4.78 (d, J = 10.8 Hz, 1H), 4.55 (d, J
= 10.9 Hz, 1H), 4.48 (s, 2H), 4.38 (d, J = 9.9 Hz, 1H, H-1), 4.05
(ddd, J = 10.8, 5.6, 2.5 Hz, 1H), 3.94 (ddd, J = 10.8, 6.8, 2.5 Hz, 1H),
3.82 (s, 7H), 3.79 (s, 3H), 3.74−3.67 (m, 2H, H-6a), 3.64−3.58 (m,
3H, H-3, H-6b), 3.49 (t, J = 9.4 Hz, 1H, H-4), 3.39−3.31 (m, 2H, H-
2, H-5). 13C{1H} NMR (126 MHz, CDCl3): δ 162.3, 162.1, 138.4,
138.3, 137.9, 128.5, 128.4, 128.3, 128.0, 127.9, 127.8, 127.80, 127.79,
127.5, 100.0, 91.2, 88.7 (C-1), 87.2 (C-3), 81.6 (C-2), 79.6 (C-5),
78.2 (C-4), 75.8, 75.0, 74.9, 73.6, 69.6 (C-6), 61.9, 56.2, 55.3. HRMS
(ESI-TOF) (m/z): [M + Na]+ calcd for C38H44O9SNa, 699.2604;
found, 699.2583.
Phenyl 3,4,6-Tri-O-benzyl-1-thio-β-D-galactopyranoside (11a).
Using general procedure B starting from 4 (0.682g, 1.64 mmol)
and thiophenol, silica gel ﬂash column chromatography (0% to 30%
to Et2O in toluene) aﬀorded 11a (0.57 g, 1.05 mmol, 64%). TLC
(EtOAc/n-heptane, 30/70 v/v): Rf = 0.38.
1H NMR (500 MHz,
CDCl3): δ 7.56−7.53 (m, 2H), 7.52−7.48 (m, 2H), 7.39−7.17 (m,
16H), 5.70 (d, J = 5.5 Hz), 4.89 (d, J = 11.4 Hz, 2H), 4.75 (dd, J =
13.9, 11.7 Hz, 2H), 4.70−4.63 (m, 2H), 4.59−4.56 (d, J = 7.0 Hz,
2H), 4.55−4.41 (m, 2H, H-1), 4.01 (t, J = 9.4 Hz, H-2), 3.98 (d, J =
2.7 Hz, H-4), 3.67−3.64 (m, 3H, H-6, H-5), 3.58 (dd, J = 9.4, 6.0 Hz,
1H, H-6), 3.47 (dd, J = 9.2, 2.8 Hz, H-3). 13C{1H} NMR (126 MHz,
CDCl3): δ 138.7, 138.4, 138.0, 137.9, 137.9, 137.8, 134.0, 132.6,
132.2, 132.0, 128.9, 128.8, 128.63, 128.58, 128.55, 128.45, 128.42,
128.3, 128.2, 128.02, 128.01, 127.93, 127.87, 127.84, 127.81, 127.79,
127.77, 127.74, 127.69, 127.57, 127.5, 127.3, 127.0, 88.5 (C-1), 83.2
(C-3), 77.6 (C-5), 74.8, 74.4, 73.6, 73.5, 73.2 (C-4), 72.4, 72.4, 69.1
(C-2), 68.7 (C-6). HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C33H34O5SNa, 565.2024; found, 565.2014.
4-Methoxyphenyl 3,4,6-tri-O-benzyl-1-thio-β-D-galactopyrano-
side (12a). Using general procedure B starting from 4 (530 mg,
1.28 mmol) and 4-methoxythiophenol, silica gel ﬂash column
chromatography (0% to 30% Et2O in toluene) aﬀorded 12a (0.19
g, 0.331 mmol, 26%). TLC (Et2O/toluene, 20/80 v/v): Rf = 0.65.
1H
NMR (500 MHz, CDCl3): δ 7.49 (d, J = 8.7 Hz, 2H), 7.38−7.18 (m,
15H), 6.75 (d, J = 8.8 Hz, 2H), 4.87 (d, J = 11.5 Hz, 1H), 4.69 (dd, J
= 11.9 Hz, 2H), 4.55 (d, J = 11.5 Hz, 1H), 4.46 (q, J = 11.7 Hz, 2H),
4.40 (d, J = 9.5 Hz, H-1), 3.95 (d, J = 2.6 Hz, H-4), 3.91 (td, J = 9.4,
1.5 Hz, H-2), 3.74 (s, 3H), 3.69−3.58 (m, H-6a, H-6b, H-5), 3.45
(dd, J = 9.3, 2.7 Hz, H-3), 2.45 (d, J = 1.8 Hz, 1H). 13C{1H} NMR
(126 MHz, CDCl3): δ 159.8, 138.7, 138.1, 137.9, 135.3, 128.54,
128.45, 128.1, 127.92, 127.85, 127.83, 127.7, 127.6, 127.4, 122.2,
114.4, 88.9 (C-1), 83.2 (C-3), 77.6 (C-5), 74.3, 73.6, 73.3 (C-4),
72.4, 69.0 (C-2), 68.7 (C-6). HRMS (ESI-TOF) (m/z): [M + Na]+
calcd for C34H36O6SNa, 595.2130; found, 595.2110.
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2,6-Dimethoxyphenyl 3,4,6-Tri-O-benzyl-1-thio-β-D-galactopyr-
anoside (13a). Using general procedure B starting from 4 (0.838g,
2.01 mmol and 2,6-dimethoxythiophenol, silica gel ﬂash column
chromatography (0% to 30% Et2O in toluene) aﬀorded 13a (0.667 g,
1.11 mmol, 55%). TLC (Et2O/toluene, 20/80 v/v): Rf = 0.52.
1H
NMR (500 MHz, CDCl3): δ 7.40−7.19 (m, 15H), 7.16−7.11 (m,
2H), 6.59 (d, J = 8.4 Hz, 1H), 4.89 (d, J = 11.7 Hz, 1H), 4.83 (d, J =
12.2 Hz, 1H), 4.71 (d, J = 12.0 Hz, 1H), 4.49 (d, J = 11.7 Hz, 1H),
4.42 (dd, J = 11.7 Hz, 2H), 4.26 (d, J = 9.4 Hz, H-1), 3.90−3.69 (m,
3H, H-2, H-4), 3.65−3.50 (m, H-5, H-6a, H-6b), 3.45 (dd, J = 9.4, 2.8
Hz, H-3). 13C{1H} NMR (126 MHz, CDCl3): δ 162.0, 139.1, 138.7,
138.0, 131.3, 128.4, 128.3, 128.0, 127.9, 127.7, 127.53, 127.47, 127.3,
127.1, 104.7, 89.8 (C-1), 82.7 (C-3), 77.6 (C-5), 74.14 (C-4), 74.12,
73.5, 72.7, 70.5 (C-2), 68.5 (C-6), 56.5. HRMS (ESI-TOF) (m/z):
[M + Na]+ calcd for C35H38O7SNa, 625.2235; found, 625.2228.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-benzyl-1-thio-β-D-galacto-
pyranoside (14a). Using general procedure B starting from 4
(0.681g, 1.64 mmol and 2,4,6-trimethoxythiophenol, silica gel ﬂash
column chromatography (0% to 30% Et2O in toluene) aﬀorded 14a
(0.61 g, 0.965 mmol, 59%). TLC (EtOAc/n-heptane, 50/50 v/v): Rf
= 0.44. 1H NMR (400 MHz, CDCl3): δ 7.40−7.10 (m, 15H), 6.16 (s,
2H), 4.89 (d, J = 11.8 Hz, 1H), 4.84 (d, J = 12.2 Hz, 1H), 4.71 (d, J =
12.2 Hz, 1H), 4.44 (dt, J = 11.5 Hz, 3H), 4.17 (d, J = 9.3 Hz, H-1),
3.87 (d, J = 2.6 Hz, H-4), 3.82 (s, 3H), 3.81 (s, 6H), 3.76−3.51 (m,
H-2), 3.46 (dd, J = 9.5, 2.8 Hz, H-3, H-5, H-6a, H-6b). 13C{1H}
NMR (126 MHz, CDCl3): δ 163.0, 162.8, 162.3, 139.2, 138.7, 138.0,
128.39, 128.35, 128.0, 127.9, 127.7, 127.6, 127.5, 127.2, 127.0, 97.7,
91.6, 90.6, 89.9 (C-1), 82.7 (C-3), 77.5 (C-5), 74.2 (C-4), 74.1, 73.5,
72.8, 70.2 (C-2), 68.5 (C-6), 56.4, 56.0, 55.43, 55.41. HRMS (ESI-
TOF) (m/z): [M + Na]+ calcd for C36H40O8SNa, 655.2341; found,
655.2327.
Phenyl 3,4,6-Tri-O-benzyl-2-O-(2-hydroxyethyl)-1-thio-β-D-gal-
actopyranoside (11b). Using general procedure C starting from
11a (0.541g, 0.998 mmol), silica gel ﬂash column chromatography
(0% to 30% Et2O in toluene) aﬀorded 11b (0.117 g, 0.200 mmol,
20%). TLC (Et2O/toluene, 50/50 v/v): Rf = 0.61.
1H NMR (500
MHz, CDCl3): δ 7.55−7.51 (m, 5H), 7.36−7.13 (m, 15H), 4.89 (d, J
= 11.4 Hz, 1H), 4.73 (d, J = 11.6 Hz, 1H), 4.62 (d, J = 11.6 Hz, 1H),
4.57 (d, J = 11.5 Hz, 1H), 4.54 (d, J = 9.6 Hz, H-1), 4.45 (q, J = 11.7
Hz, 2H), 4.00 (d, J = 2.4 Hz, H-4), 3.86−3.80 (m, 2H, H-2), 3.68−
3.58 (m, 2H, H-5, H-6a, H-6b), 3.55 (dd, J = 9.3, 2.7 Hz, H-3).
13C{1H} NMR (126 MHz, CDCl3): δ 131.4, 129.1, 128.9, 128.6,
128.5, 128.2, 128.1, 128.0, 127.86, 127.84, 127.79, 127.6, 127.2, 125.3,
88.0 (C-1), 84.0 (C-3), 77.3 (C-5), 77.2 (C-2), 75.0, 74.5, 73.6, 72.9
(C-4), 72.2, 68.6 (C-6), 62.3, 60.4. HRMS (ESI-TOF) (m/z): [M +
Na]+ calcd for C35H38O6SNa, 609.2286; found, 609.2274.
4-Methoxyphenyl 3,4,6-Tri-O-benzyl-2-O-(2-hydroxyethyl)-1-
thio-β-D-galactopyranoside (12b). Using general procedure C from
12a (0.197 g, 0.344 mmol), silica gel ﬂash column chromatography
(0% to 40% EtOAc in n-heptane) aﬀorded 12b (0.142 g, 0.230 mmol
67%). TLC (Et2O/toluene, 50/50 v/v): Rf = 0.61.
1H NMR (500
MHz, CDCl3): δ 7.53−7.47 (m, 2H), 7.36−7.23 (m, 15H), 6.73 (d, J
= 8.8 Hz, 2H), 4.87 (d, J = 11.5 Hz, 1H), 4.73 (d, J = 11.6 Hz, 1H),
4.62 (d, J = 11.6 Hz, 1H), 4.55 (d, J = 11.5 Hz, 1H), 4.49−4.40 (m,
2H, H-1), 3.98 (d, J = 2.4 Hz, H-4), 3.86 (t, J = 4.4 Hz, 2H), 3.74 (s,
3H, H-2), 3.65 (dd, J = 10.4, 5.6 Hz, 2H, H-6a, H-6b), 3.59−3.51 (m,
H-3, H-5), 3.07 (t, J = 6.2 Hz, 1H). 13C{1H} NMR (126 MHz,
CDCl3): δ 159.6, 138.6, 137.8, 137.4, 134.6, 128.6, 128.4, 128.2,
128.0, 127.9, 127.84, 127.80, 127.73, 127.5, 123.4, 114.4, 88.6 (C-1),
84.0 (C-3), 77.22 (C-5), 77.17 (C-2), 75.0, 74.4, 73.6, 72.8 (C-4),
72.1, 68.6 (C-6), 62.3, 55.3. HRMS (ESI-TOF) (m/z): [M + Na]+
calcd for C36H40O7SNa, 639.2392; found, 639.2376.
2,6-Dimethoxyphenyl 3,4,6-Tri-O-benzyl-2-O-(2-hydroxyethyl)-
1-thio-β-D-galactopyranoside (13b). Using general procedure C
from 13a (0.657 g, 1.09 mmol), silica gel ﬂash column
chromatography (0% to 50% EtOAc in n-heptane) aﬀorded 13b
(0.465 g, 0.720 mmol, 66%). TLC (EtOAc/n-heptane, 30/70 v/v): Rf
= 0.35. 1H NMR (500 MHz, CDCl3): δ 7.35 (d, J = 4.6 Hz, 2H),
7.33−7.18 (m, 15H), 6.54 (d, J = 8.4 Hz, 1H), 4.88 (d, J = 11.6 Hz,
1H), 4.71 (d, J = 11.6 Hz, 1H), 4.64 (d, J = 11.6 Hz, 1H), 4.56 (d, J =
11.5 Hz, 1H), 4.44 (d, J = 9.8 Hz, H-1), 4.37 (dd, J = 11.6 Hz, 2H),
4.06 (ddd, J = 11.1, 5.6, 2.3 Hz, 1H), 3.94 (ddd, J = 11.2, 6.3, 2.0 Hz,
1H), 3.91 (d, J = 2.2 Hz, H-4), 3.82 (s, 3H), 3.79−3.73 (m, 1H, H-2),
3.71−3.64 (m, 1H), 3.62−3.53 (m, H-6a, H-6b), 3.49 (dd, J = 9.2, 2.8
Hz, H-3), 3.44 (t, J = 6.3 Hz, H-5), 1.67 (s, 1H). 13C{1H} NMR (126
MHz, CDCl3): δ 161.0, 138.7, 137.98, 137.96, 130.2, 128.5, 128.4,
128.2, 128.0, 127.8, 127.7, 127.6, 127.5, 109.3, 104.3, 88.9 (C-1), 84.7
(C-3), 78.3 (C-2), 77.5 (C-5), 75.1, 74.4, 73.5, 73.4 (C-4), 72.3, 69.1
(C-6), 61.8, 56.2. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C37H42O8SNa, 669.2498; found, 669.2484.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-benzyl-2-O-(2-hydroxyeth-
yl)-1-thio-β-D-galactopyranoside (14b). Using general procedure C
starting from 14a (0.371 g, 0.586 mmol), silica gel ﬂash column
chromatography (0% to 20% EtOAc in toluene) aﬀorded 14b (0.162
g, 0.240 mmol, 41%). TLC (EtOAc/n-heptane, 30/70 v/v): Rf = 0.30.
1H NMR (400 MHz, CDCl3): δ 7.39−7.17 (m, 15H), 6.11 (s, 2H),
4.88 (d, J = 11.6 Hz, 1H), 4.68 (dd, J = 28.1, 11.6 Hz, 2H), 4.55 (d, J
= 11.7 Hz, 1H), 4.37 (q, J = 11.6 Hz, 2H), 4.30 (d, J = 9.8 Hz, H-1),
4.06 (ddd, J = 11.3, 5.3, 2.6 Hz, 1H), 3.99−3.87 (m, 1H, H-4), 3.80
(m, 10H), 3.72 (t, J = 9.5 Hz, 1H, H-2), 3.63−3.51 (m, H-6a, H-6b),
3.48 (dd, J = 9.2, 2.8 Hz, H-3), 3.42 (t, J = 6.3 Hz, H-5). 13C{1H}
NMR (126 MHz, CDCl3): δ 162.20, 162.15, 138.7, 138.03, 138.02,
128.5, 128.4, 128.2, 127.97, 127.95, 127.8, 127.7, 127.6, 127.5, 100.8,
91.2, 89.8 (C-1), 84.7 (C-3), 78.1 (C-2), 77.4 (C-5), 75.1, 74.4, 73.6,
73.4 (C-4), 72.3, 69.2 (C-6), 61.8, 56.2, 55.4. HRMS (ESI-TOF) (m/
z): [M + Na]+ calcd for C38H44O9SNa, 699.2603; found, 699.2593.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-(4-chlorobenzyl)-1-thio-β-D-
glucopyranoside (15a). Using general procedure B starting from 2
(1.0 g, 1.9 mmol), the crude product was puriﬁed by silica gel ﬂash
column chromatography (0% to 30% EtOAc in n-heptane) to aﬀord
15a as a white solid (0.84 g, 1.2 mmol, 61%). TLC (EtOAc/n-
heptane, 40/60 v/v): Rf = 0.52.
1H NMR (500 MHz, CDCl3): δ
7.28−7.19 (m, 8H), 7.12 (d, J = 8.4 Hz, 2H), 7.05 (d, J = 8.4 Hz,
2H), 6.11 (s, 2H), 4.99 (d, J = 11.4 Hz, 1H), 4.75−4.62 (m, 2H),
4.50 (d, J = 11.7 Hz, 1H), 4.47 (d, J = 11.3 Hz, 1H), 4.38 (d, J = 11.7
Hz, 1H), 4.18 (d, J = 9.4 Hz, 1H, H-1), 3.85 (d, J = 2.0 Hz, 1H), 3.81
(s, 9H), 3.77−3.73 (m, 2H, H-6a, H-6b), 3.56 (t, J = 8.7 Hz, 1H, H-
3), 3.47 (t, J = 9.2 Hz, 1H, H-4), 3.42 (dt, J = 9.7, 2.5 Hz, 1H, H-5),
3.26 (td, J = 9.1, 2.0 Hz, 1H, H-2). 13C{1H} NMR (126 MHz,
CDCl3): δ 163.1, 163.0, 137.3, 136.9, 136.7, 133.34, 133.26, 133.24,
129.2, 129.0, 128.9, 128.42, 128.39, 91.5, 88.4 (C-1), 85.4 (C-3), 79.9
(C-5), 76.7 (C-4), 74.2, 74.1, 73.2 (C-2), 72.9, 69.0 (C-6), 56.3, 55.4.
HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for C36H37Cl3O8SNa,
757.1172; found, 757.1148.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-(2,4-dichlorobenzyl)-1-thio-
β-D-glucopyranoside (16a). Using general procedure B starting
from 3 (2.01 g, 3.22 mmol), the crude product was puriﬁed by silica
gel ﬂash column chromatography (0% to 30% EtOAc in n-heptane) to
aﬀord 16a as a white solid (1.35 g, 1.61 mmol, 50%). TLC (EtOAc/n-
heptane, 40/60 v/v): Rf = 0.52.
1H NMR (500 MHz, CDCl3): δ 7.41
(d, J = 8.2 Hz, 1H), 7.33 (d, J = 2.0 Hz, 1H), 7.27 (d, J = 2.1 Hz, 1H),
7.25−7.23 (m, 2H), 7.18−7.13 (m, 3H), 7.09 (dd, J = 8.3, 2.1 Hz,
1H), 6.12 (s, 2H), 5.08 (d, J = 12.8 Hz, 1H), 4.77 (m, 2H), 4.58 (d, J
= 12.8 Hz, 1H), 4.52 (d, J = 12.9 Hz, 1H), 4.46 (d, J = 12.8 Hz, 1H),
4.20 (d, J = 9.5 Hz, 1H, H-1), 3.85 (d, J = 2.0 Hz, 1H), 3.81 (m, 11H,
H-6a, H-6b), 3.62 (t, J = 8.7 Hz, 1H, H-3), 3.55 (dd, J = 9.7, 8.7 Hz,
1H, H-4), 3.46 (dt, J = 9.7, 2.6 Hz, 1H, H-5), 3.27 (ddd, J = 9.5, 8.7,
2.0 Hz, 1H, H-2). 13C{1H} NMR (126 MHz, CDCl3): δ 163.2, 163.1,
135.2, 134.74, 134.73, 133.67, 133.63, 133.57, 133.4, 133.2, 133.0,
130.1, 130.0, 129.6, 128.93, 128.85, 127.0, 126.9, 96.1, 91.5, 88.4 (C-
1), 85.7 (C-3), 79.4 (C-5) 76.7 (C-4), 73.2 (C-2), 71.2, 71.1, 70.0,
69.6 (C-6), 56.4, 55.4. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd
for C36H34Cl6O8SNa, 859.0003; found, 858.9974.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-(4-chlorobenzyl)-1-thio-β-D-
galactopyranoside (17a). Using general procedure B starting from 5
(0.97 g, 1.87 mmol) and 2,4,6-trimethoxythiophenol, silica gel ﬂash
column chromatography (0% to 20% to Et2O in toluene) aﬀorded
17a (0.85 g, 1.12 mmol, 60%). TLC (Et2O/toluene, 20/80 v/v): Rf =
0.39. 1H NMR (500 MHz, CDCl3): δ 7.36−6.98 (m, 12H), 6.17 (s,
2H), 4.82 (d, J = 11.9 Hz, 1H), 4.80 (d, J = 11.9 Hz, 1H), 4.69−4.63
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(m, 1H), 4.44 (d, J = 11.9 Hz, 1H), 4.39 (d, J = 11.9 Hz, 1H), 4.34
(d, J = 11.9 Hz, 1H), 4.15 (d, J = 9.3 Hz, H-1), 3.86−3.78 (m, 9H, H-
4), 3.73−3.65 (m, H-2), 3.61−3.49 (m, H-5, H-6a, H-6b), 3.43 (dd, J
= 9.4, 2.8 Hz, H-3). 13C{1H} NMR (126 MHz, CDCl3): δ 163.0,
162.9, 137.5, 137.2, 136.4, 133.6, 133.2, 132.7, 129.1, 128.8, 128.6,
128.5, 128.2, 128.1, 97.5, 91.5, 90.6, 89.8 (C-1), 82.6 (C-3), 77.2 (C-
5), 74.4 (C-4), 73.2, 72.7, 72.1, 70.3 (C-2), 68.3 (C-6), 56.4, 56.0,
55.4. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C36H37Cl3O8SNa, 757.1172; found, 757.1148.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-(2,4-dichlorobenzyl)-1-thio-
β-D-galactopyranoside (18a). Using general procedure B starting
from 6 (1.05 g, 1.70 mmol) and 2,4,6-trimethoxythiophenol, silica gel
ﬂash column chromatography (0% to 20% Et2O in toluene) aﬀorded
18a (0.71g, 0.851 mmol, 50%). TLC (Et2O/toluene, 20/80 v/v): Rf =
0.49. 1H NMR (500 MHz, CDCl3): δ 7.48−7.00 (m, 9H), 6.19 (s,
2H), 4.92 (d, J = 13.3 Hz, 1H), 4.85 (d, J = 13.5 Hz, 1H), 4.75 (d, J =
13.4 Hz, 1H), 4.54 (d, J = 12.7 Hz, 1H), 4.48 (d, J = 13.5 Hz, 1H),
4.44 (d, J = 12.7 Hz, 1H), 4.20 (d, J = 9.0 Hz, H-1), 3.96 (d, J = 2.5
Hz, H-4), 3.89−3.75 (m, 9H), 3.71−3.56 (m, H-2, H-5, H-6a, H-6b),
3.53 (dd, J = 9.2, 2.5 Hz, H-3). 13C{1H} NMR (126 MHz, CDCl3): δ
163.2, 162.9, 135.5, 135.0, 134.1, 134.0, 133.8, 133.6, 133.1, 133.0,
132.0, 130.2, 129.8, 129.2, 129.0, 128.94, 128.85, 128.4, 128.2, 127.1,
126.8, 125.3, 97.1, 91.5, 89.5 (C-1), 82.9 (C-3), 76.8 (C-5), 74.8 (C-
4), 70.6, 70.1 (C-2), 69.9, 69.7, 68.4 (C-6), 56.4, 55.4. HRMS (ESI-
TOF) (m/z): [M + Na]+ calcd for C36H34Cl6O8SNa, 859.0003;
found, 859.0024.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-(4-chlorobenzyl)-2-O-(2-hy-
droxyethyl)-1-thio-β-D-glucopyranoside (15b). Using general pro-
cedure C starting from 15a (0.127 g,0.172 mmol), the crude product
was puriﬁed by silica gel ﬂash column chromatography (20% to 60%
EtOAc in n-heptane), aﬀording 15b as a white solid (0.11 g, 0.141
mmol, 82%). TLC (EtOAc/n-heptane, 40/60 v/v): Rf = 0.24.
1H
NMR (500 MHz, CDCl3): δ 7.31−7.19 (m, 9H), 7.18−7.13 (m, 2H),
7.05 (d, J = 8.4 Hz, 2H), 6.12 (s, 2H), 4.84 (d, J = 11.3 Hz, 1H), 4.75
(d, J = 11.3 Hz, 1H), 4.66 (d, J = 11.3 Hz, 1H), 4.49 (d, J = 11.3 Hz,
1H), 4.45 (d, J = 11.9 Hz, 1H), 4.42 (d, J = 12.0 Hz, 1H), 4.39 (d, J =
9.9 Hz, 1H, H-1), 4.01 (ddd, J = 10.7, 5.5, 2.5 Hz, 1H), 3.93 (ddd, J =
10.7, 6.8, 2.5 Hz, 1H), 3.82 (s, 6H), 3.80 (s, 3H), 3.74−3.68 (m, 1H),
3.67 (dd, J = 11.4, 2.0 Hz, 1H, H-6a), 3.63−3.51 (m, 2H, H-3, H-6b),
3.45 (t, J = 9.4 Hz, 1H, H-4), 3.37−3.28 (m, 2H, H-2, H-5). 13C{1H}
NMR (126 MHz, CDCl3): δ 162.4, 162.1, 136.8, 136.6, 136.3, 133.56,
133.54, 133.3, 129.1, 128.9, 128.6, 128.5, 128.4, 99.7, 91.2, 88.5 (C-
1), 87.0 (C-4), 81.7 (C-2), 79.4 (C-5), 78.1 (C-3), 74.8, 74.7, 74.0,
72.8, 69.4 (C-6), 61.8, 56.2, 55.3. HRMS (ESI-TOF) (m/z): [M +
Na]+ calcd for C38H41Cl3O9SNa, 801.1435; found, 801.1399.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-(2,4-dichlorobenzyl)-2-O-(2-
hydroxyethyl)-1-thio-β-D-glucopyranoside (16b). Using general
procedure C starting from 16a (0.593 g, 0.710 mmol), the crude
product was puriﬁed by silica gel ﬂash column chromatography (30%
to 60% EtOAc in n-heptane) aﬀording 16b as a white solid (0.45 g,
0.511 mmol, 72%). TLC (EtOAc/n-heptane, 40/60 v/v): Rf = 0.35.
1H NMR (500 MHz, CDCl3): δ 7.39 (d, J = 8.3 Hz, 1H), 7.33 (d, J =
2.1 Hz, 1H), 7.30 (d, J = 8.3 Hz, 1H), 7.29 (d, J = 2.1 Hz, 1H), 7.24
(d, J = 2.0 Hz, 1H), 7.19 (dd, J = 8.3, 2.1 Hz, 1H), 7.18−7.13 (m,
2H), 7.10 (dd, J = 8.3, 2.0 Hz, 1H), 6.12 (s, 2H), 4.92 (d, J = 13.1 Hz,
1H), 4.81 (d, J = 13.1 Hz, 1H), 4.71 (d, J = 12.7 Hz, 1H), 4.59 (d, J =
12.7 Hz, 1H), 4.54 (d, J = 13.0 Hz, 1H), 4.47 (d, J = 13.0 Hz, 1H),
4.41 (d, J = 9.9 Hz, 1H, H-1), 4.01−3.87 (m, 2H), 3.83 (s, 6H), 3.80
(s, 3H), 3.79−3.67 (m, 5H, H-6), 3.64 (t, J = 8.8 Hz, 1H, H-3), 3.55
(t, J = 9.4 Hz, 1H, H-4), 3.49 (s, 1H), 3.41−3.32 (m, 2H, H-2, H-5).
13C{1H} NMR (126 MHz, CDCl3): δ 162.4, 162.1, 134.7, 134.6,
134.3, 133.9, 133.7, 133.4, 133.1, 132.7, 130.1, 129.7, 129.3, 129.0,
128.94, 128.92, 127.1, 127.00, 126.98, 99.7, 91.2, 88.7 (C-1), 87.2 (C-
3), 81.7 (C-2), 79.0 (C-5), 78.1 (C-4), 74.9, 71.7, 71.1, 70.0 (C-6),
61.9, 56.2, 55.4. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C38H38Cl6O9SNa, 903.0265; found, 903.0224.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-(4-cyanobenzyl)-2-O-(2-hy-
droxyethyl)-1-thio-β-D-glucopyranoside (19b). Compound 15b
(0.15 g, 0.2 mmol), tBuXPhos-Pd-G3 (0.01 mmol, 5 mol %),
tBuXPhos (0.01 mmol, 5 mol %), and K4[Fe(CN)6]·3H2O (0.3
mmol) were added to a solution of 1,4-dioxane (1.3 mL) and 0.05 M
KOAc in degassed water (1.3 mL) The mixture was vigorously stirred
at 100 °C for 4 h. The reaction was cooled to rt and diluted with
EtOAc (50 mL) and brine (50 mL). The aqueous layer was further
extracted with EtOAc (2 × 25 mL). The combined organic layers
were dried (MgSO4), ﬁltered, and concentrated under reduced
pressure. The residue was puriﬁed using silica gel ﬂash column
chromatography (0−80% EtOAc in n-heptane to obtain product 19b
(0.16 g, 93%). TLC (EtOAc/n-heptane, 60/40 v/v): Rf = 0.16.
1H
NMR (500 MHz, CDCl3): δ 7.61−7.22 (m, 12H), 6.13 (s, 2H), 4.96
(d, J = 12.5 Hz, 1H), 4.79 (d, J = 12.5 Hz, 1H), 4.74 (d, J = 12.5 Hz,
1H), 4.62 (d, J = 12.5 Hz, 1H), 4.53 (q, J = 12.8 Hz, 2H), 4.45 (d, J =
9.9 Hz, H-1), 3.96 (dd, J = 5.2, 2.7 Hz, 2H), 3.82 (d, J = 6.5 Hz, 9H),
3.69 (m, 1H, H-6a, H-6b), 3.61 (t, J = 8.9 Hz, H-3), 3.51 (t, J = 9.4
Hz, H-4), 3.41−3.33 (m, H-2, H-5). 13C{1H} NMR (126 MHz,
CDCl3): δ 162.5, 162.1, 143.8, 143.4, 143.2, 132.3, 132.2, 132.1,
127.8, 127.5, 127.4, 118.7, 118.6, 118.5, 111.64, 111.61, 111.3, 99.4,
91.2, 88.3 (C-1), 87.2 (C-3), 81.9 (C-2), 79.3 (C-5), 78.3 (C-4), 74.9,
74.4, 73.7, 72.7, 69.7 (C-6), 61.9, 56.3, 55.4. HRMS (ESI-TOF) (m/
z): [M + Na]+ calcd for C41H41N3O9SNa, 774.2461; found, 774.2465.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-(4-chlorobenzyl)-2-O-(2-hy-
droxyethyl)-1-thio-β-D-galactopyranoside (17b). Using general
procedure C starting from 17a (0.55g, 0.748 mmol), silica gel ﬂash
column chromatography (0% to 50% Et2O in toluene) aﬀorded 17b
(0.51 g, 0.634 mmol, 85%). TLC (Et2O/toluene, 30/70 v/v): Rf =
0.21. 1H NMR (500 MHz, CDCl3): δ 7.35−7.09 (m, 12H), 6.11 (s,
2H), 4.78 (d, J = 11.9 Hz, 1H), 4.63 (m, 2H), 4.48 (d, J = 11.9 Hz,
1H), 4.39 (d, J = 11.7 Hz, 1H), 4.32−4.27 (m, 1H, H-1), 4.04 (ddd, J
= 10.9, 5.6, 2.3 Hz, 1H), 3.96−3.89 (m, 1H), 3.81−3.72 (m, 10H, H-
4), 3.68 (t, J = 9.5 Hz, 1H), 3.60−3.51 (m, H-6a, H-6b), 3.49−3.39
(m, H-3, H-5). 13C{1H} NMR (126 MHz, CDCl3): δ 162.3, 162.1,
137.0, 136.40, 136.39, 133.63, 133.58, 133.2, 129.2, 129.0, 128.8,
128.7, 128.5, 128.3, 100.5, 91.1, 89.8 (C-1), 84.6 (C-3), 78.2 (C-2),
77.2 (C-5), 75.1, 73.8 (C-4), 73.6, 72.7, 71.6, 69.0 (C-6), 61.8, 56.2,
55.4. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C38H41Cl3O9SNa, 801.1434; found, 801.1419.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-(2,4-dichlorobenzyl)-2-O-(2-
hydroxyethyl)-1-thio-β-D-galactopyranoside (18b). Using general
procedure C starting from 18a (0.500 mg, 0.599 mmol), silica gel
ﬂash column chromatography (0% to 20% Et2O in toluene) aﬀorded
18b (0.39 g, 0.443 mmol, 74%). TLC (Et2O/toluene, 30/70 v/v): Rf
= 0.37. 1H NMR (500 MHz, CDCl3): δ 7.48−7.10 (m, 9H), 6.13 (s,
2H), 4.91 (d, J = 13.2 Hz, 1H), 4.75 (m, 2H), 4.55 (d, J = 13.2 Hz,
1H), 4.51 (d, J = 12.6 Hz, 1H), 4.40 (d, J = 12.6 Hz, 1H), 4.33 (d, J =
9.8 Hz, H-1), 4.05−3.99 (m, 1H, H-4), 3.93−3.87 (m, 1H), 3.86−
3.75 (m, 10H), 3.76−3.64 (m, 1H, H-6a, H-2), 3.61 (dd, J = 9.3, 5.5
Hz, H-6b), 3.58−3.50 (m, H-3, H-5). 13C{1H} NMR (126 MHz,
CDCl3): δ 162.4, 162.2, 135.0, 134.2, 134.1, 134.0, 133.9, 133.4,
133.2, 132.4, 130.4, 129.76, 129.75, 129.2, 129.1, 129.0, 128.6, 128.2,
127.3, 127.01, 127.00, 125.3, 100.3, 91.1, 90.0 (C-1), 84.9 (C-3), 78.2
(C-2), 76.7 (C-5), 75.2, 74.60 (C-4), 71.1, 70.0, 69.1, 68.9 (C-6),
61.8, 56.2, 55.4. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C38H38Cl6O9SNa, 903.0265; found, 903.0303.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-(4-cyanobenzyl)- 2-O-(2-hy-
droxyethyl)-1-thio-β-D-galactopyranoside (20b). Compound 17b
(0.178 mg, 0.222 mmol), tBuXPhos-Pd-G3 (0.01 mmol, 5 mol %),
tBuXPhos (0.01 mmol, 5 mol %), and K4[Fe(CN)6]·3H2O (0.3
mmol) were added to a solution of dioxane (1.3 mL) and 0.05 M
KOAc in degassed water (1.3 mL) The mixture was vigorously at 100
°C for 4 h. The reaction was cooled to rt and diluted with EtOAc (50
mL) and brine (50 mL). The aqueous layer was further extracted with
EtOAc (2 × 25 mL). The combined organic layers were dried
(MgSO4), ﬁltered, and concentrated under reduced pressure. The
residue was puriﬁed using silica gel ﬂash column chromatography (0−
100% EtOAc in n-heptane to obtain the product 20b (0.16 g, 0.207
mmol, 93%). TLC (EtOAc/n-heptane, 60/40 v/v): Rf = 0.08.
1H
NMR (500 MHz, CDCl3): δ 7.67−7.24 (m, 12H), 6.13 (s, 1H), 4.92
(d, J = 12.7 Hz, 1H), 4.79 (s, 2H), 4.57 (d, J = 12.7 Hz, 1H), 4.50 (d,
J = 12.7 Hz, 1H), 4.42 (d, J = 12.7 Hz, 1H), 4.35 (d, J = 9.8 Hz, H-1),
4.03 (ddd, J = 10.7, 5.5, 2.3 Hz, 1H), 3.97−3.90 (m, 1H, H-4), 3.82
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(m, 10H), 3.75−3.58 (m, 1H, H-2, H-6a, H-6b), 3.55−3.48 (m, H-3,
H-5). 13C{1H} NMR (126 MHz, CDCl3): δ 162.4, 162.2, 143.8,
143.3, 143.2, 132.4, 132.2, 132.1, 127.8, 127.5, 127.4, 118.7, 118.60,
118.55, 111.7, 111.6, 111.3, 100.1, 91.2, 89.7 (C-1), 84.7 (C-3), 78.4
(C-2), 76.9 (C-5), 75.3, 74.8 (C-4), 73.7, 72.5, 71.6, 69.3 (C-6), 61.8,
56.2, 55.4. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C41H41N3O9SNa, 774.2461; found, 774.2448.
Methyl 3,4,6-Tribenzyl-2-O-(2-benzenethioethyl)-α/β-D-gluco-
pyranosyl-(1→6)-2,3,4-O-tribenzoyl-α-D-glucopyranoside (22).
Using general procedure E and donor 7b (53 mg, 0.090 mmol),
silica gel ﬂash column chromatography (0% to 40% EtOAc in n-
heptane) aﬀorded 22 as an anomeric mixture (69 mg, 0.064 mmol,
71%). TLC (EtOAc/n-heptane, 40/60 v/v): Rf = 0.5.
1H NMR (500
MHz, CDCl3): δ 7.98 (d, J = 7.8 Hz, 2H), 7.93 (d, J = 7.8 Hz, 2H),
7.85 (d, J = 7.8 Hz, 2H), 7.55−7.44 (m, 2H), 7.44−7.17 (m, 24H),
7.17−7.05 (m, 3H), 6.14 (t, J = 9.9 Hz, 1H (H-3′)), 5.53 (t, J = 9.9
Hz, 1H (H-4′)), 5.25 (dd, J = 10.3, 3.7 Hz, 1H (H-2′)), 5.18 (d, J =
3.7 Hz, 1H (H-1′)), 4.92 (d, J = 3.5 Hz, 1H (H-1)), 4.87 (d, J = 11.0
Hz, 1H), 4.80 (d, J = 11.1 Hz, 1H), 4.73 (d, J = 11.0 Hz, 1H), 4.55
(d, J = 12.1 Hz, 1H), 4.45 (d, J = 11.0 Hz, 1H), 4.39 (d, J = 12.1 Hz,
1H), 4.32 (ddd, J = 9.7, 6.6, 2.0 Hz, 1H (H-5′)), 3.93−3.83 (m, 3H
(H-6′, H-3)), 3.83−3.75 (m, 2H, H-5), 3.72−3.59 (m, 3H (H-6′, H-
4, H-6)), 3.52 (dd, J = 10.9, 2.0 Hz, 1H, H-6), 3.48−3.39 (m, 4H (H-
2)), 3.17−3.00 (m, 2H). 13C{1H} NMR (126 MHz, CDCl3): δ
165.82, 165.78, 165.2, 138.8, 138.5, 137.9, 133.3, 133.0, 129.91,
129.89, 129.86, 129.81, 129.6, 129.4, 129.2, 129.1, 128.9, 128.40,
128.38, 128.36, 128.31, 128.30, 128.23, 128.22, 127.88, 127.86,
127.61, 127.60, 127.5, 126.1, 97.0 (C-1), 96.7 (C-1′), 81.4 (C-3),
81.0 (C-2), 77.5 (C-4), 75.4, 74.8, 73.4, 72.2 (C-2′), 70.6 (C-3′), 70.3
(C-5), 69.9, 69.6 (C-4′), 68.5 (C-5′), 68.2 (C-6), 66.6 (C-6′), 55.6,
33.4. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for C63H62O14SNa,
1097.3758; found, 1097.3798.
Methyl 3,4,6-Tribenzyl-2-O-(2-(4-methoxybenzenethio)ethyl)-α-
D-glucopyranosyl-(1→6)-2,3,4-O-tribenzoyl-α-D-glucopyranoside
(23). Using general procedure E and donor 8b (68 mg, 0.111 mmol),
silica gel ﬂash column chromatography (0% to 40% EtOAc in n-
heptane) aﬀorded 23 as an anomeric mixture (76 mg, 0.069 mmol
62%). TLC (EtOAc/n-heptane, 40/60 v/v): Rf = 0.5.
1H NMR (500
MHz, CDCl3): δ 7.98 (d, J = 7.7 Hz, 2H), 7.92 (d, J = 7.7 Hz, 2H),
7.85 (d, J = 7.7 Hz, 2H), 7.49 (dt, J = 16.8, 7.4 Hz, 2H), 7.44−7.20
(m, 22H), 7.14−7.05 (m, 2H), 6.78 (d, J = 8.3 Hz, 2H), 6.13 (t, J =
9.9 Hz, 1H (H-3′)), 5.53 (t, J = 9.9 Hz, 1H (H-4′)), 5.25 (dd, J =
10.2, 3.7 Hz, 1H (H-2′)), 5.18 (d, J = 3.7 Hz, 1H (H-1′)), 4.92 (d, J =
3.5 Hz, 1H (H-1)), 4.86 (d, J = 11.0 Hz, 1H), 4.79 (d, J = 11.0 Hz,
1H), 4.71 (d, J = 11.0 Hz, 1H), 4.55 (d, J = 12.2 Hz, 1H), 4.44 (d, J =
11.0 Hz, 1H), 4.39 (d, J = 12.1 Hz, 1H), 4.32 (ddd, J = 9.8, 6.8, 2.2
Hz, 1H (H-5′)), 3.92−3.81 (m, 3H (H-6′, H-3, H-5)), 3.81−3.66 (m,
6H (H-6′)), 3.66−3.56 (m, 2H (H-4, H-6)), 3.52 (dd, J = 10.7, 2.0
Hz, 1H (H-6)), 3.46−3.37 (m, 4H (H-2)), 3.07−2.88 (m, 2H).
13C{1H} NMR (126 MHz, CDCl3): δ 165.82, 165.78, 165.3, 159.0,
138.8, 138.5, 137.9, 133.5, 133.3, 133.0, 129.91, 129.89, 129.7, 129.2,
129.1, 128.9, 128.38, 128.36, 128.32, 128.29, 128.24, 128.22, 127.91,
127.87, 127.62, 127.60, 127.5, 125.8, 114.6, 97.1 (C-1), 96.7 (C-1′),
81.4 (C-3), 80.9 (C-2), 77.5 (C-4), 75.4, 74.8, 73.4, 72.2 (C-2′), 70.6
(C-3′), 70.3 (C-5), 70.1, 69.6 (C-4′), 68.5 (C-5′), 68.2 (C-6), 66.6
(C-6′), 55.6, 55.3, 35.4. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd
for C64H64O15SNa, 1127, 3864; found, 1127, 3879.
Methyl 3,4,6-Tribenzyl-2-O-(2-(2,6-dimethoxybenzenethio)-
ethyl)-α-D-glucopyranosyl-(1→6)-2,3,4-O-tribenzoyl-α-D-glucopyr-
anoside (24). Using general procedure E and donor 9b (35 mg, 0.054
mmol), silica gel ﬂash column chromatography (0% to 40% EtOAc in
n-heptane) aﬀorded 24 (51 mg, 0.045 mmol, 83%) as an α/β mixture.
TLC (EtOAc/n-heptane, 40/60 v/v): Rf = 0.4.
1H NMR (500 MHz,
CDCl3): δ 8.00−7.95 (m, 2H), 7.95−7.89 (m, 2H), 7.85 (dd, J = 8.4,
1.4 Hz, 2H), 7.55−7.44 (m, 2H), 7.39 (dt, J = 18.0, 7.7 Hz, 3H),
7.35−7.17 (m, 20H), 7.11 (dd, J = 7.7, 1.9 Hz, 2H), 6.50 (d, J = 8.4
Hz, 2H), 6.12 (t, J = 9.8 Hz, 1H (H-3′)), 5.49−5.41 (m, 1H (H-4′)),
5.23 (dd, J = 10.2, 3.7 Hz, 1H (H-2′)), 5.16 (d, J = 3.8 Hz, 1H (H-
1′)), 4.92 (d, J = 3.4 Hz, 1H (H-1)), 4.84 (d, J = 10.9 Hz, 1H), 4.78
(d, J = 11.0 Hz, 1H), 4.67 (d, J = 10.9 Hz, 1H), 4.44 (d, J = 11.1 Hz,
1H), 4.39 (d, J = 12.1 Hz, 1H), 4.33 (ddd, J = 9.9, 7.3, 2.1 Hz, 1H
(H-5′)), 3.93−3.76 (m, 9H (H-6′, H-3, H-5)), 3.72−3.63 (m, 4H
(H-6′, H-6)), 3.60 (dd, J = 10.1, 8.9 Hz, 1H (H-4)), 3.53 (dd, J =
10.7, 2.0 Hz, 1H (H-6)), 3.50−3.36 (m, 4H (H-2)), 3.01 (dt, J =
12.9, 7.3 Hz, 1H), 2.97−2.87 (m, 1H). 13C{1H} NMR (126 MHz,
CDCl3): δ 165.8, 165.7, 165.3, 161.1, 138.8, 138.6, 138.0, 133.3,
133.0, 129.9, 129.8, 129.6, 129.2, 129.1, 128.9, 128.37, 128.35, 128.30,
128.25, 128.22, 128.19, 128.0, 127.9, 127.6, 127.5, 127.41, 127.40,
109.4, 104.0, 97.1 (C-1), 96.6 (C-1′), 81.5 (C-3), 81.0 (C-2), 77.4
(C-4), 75.3, 74.7, 73.4, 72.2 (C-2′), 71.0, 70.6 (C-3′), 70.3 (C-5),
69.7 (C-4′), 68.4 (C-5′), 68.3 (C-6), 66.8 (C-6′), 56.1, 55.6, 33.4.
HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for C65H66O16SNa,
1157.3969; found, 1157.3954.
Methyl 3,4,6-Tri-O-benzyl-2-O-(2-(2,4,6-trimethoxyphenylthio)-
ethyl)-α-D-glucopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-α-D-glucopyr-
anoside (25). Using general procedure E starting from glucosyl donor
10b (48 mg; 0.071 mmol), the crude product was puriﬁed by silica gel
ﬂash column chromatography (10% to 40% EtOAc in n-heptane),
aﬀording 25 as an anomeric mixture (63 mg, 76%). TLC (EtOAc/n-
heptane, 40/60 v/v): Rf = 0.35.
1H NMR (500 MHz, CDCl3): δ 7.97
(dd, J = 8.4, 1.4 Hz, 2H), 7.92 (dd, J = 8.3, 1.4 Hz, 2H), 7.85 (dd, J =
8.4, 1.4 Hz, 2H), 7.53−7.44 (m, 2H), 7.43−7.34 (m, 3H), 7.34−7.22
(m, 17H), 7.11 (dd, J = 7.7, 1.8 Hz, 2H), 6.11 (m, 3H (H-3′)), 5.45
(dd, J = 10.3, 9.5 Hz, 1H (H-4′)), 5.23 (dd, J = 10.2, 3.7 Hz, 1H (H-
2′)), 5.16 (d, J = 3.7 Hz, 1H (H-1′)), 4.93 (d, J = 3.4 Hz, 1H (H-1)),
4.84 (d, J = 10.9 Hz, 1H), 4.79 (d, J = 11.1 Hz, 1H), 4.66 (d, J = 10.9
Hz, 1H), 4.56 (d, J = 12.1 Hz, 1H), 4.43 (d, J = 11.1 Hz, 1H), 4.39
(d, J = 12.1 Hz, 1H), 4.34 (ddd, J = 10.0, 7.4, 2.1 Hz, 1H (H-5′)),
3.92−3.86 (m, 2H (H-6′, H-5)), 3.79, m, 10H (H-3)), 3.72−3.58 (m,
5H (H-6′, H-4, H-6)), 3.53 (dd, J = 10.7, 2.0 Hz, 1H (H-6)), 3.44−
3.36 (m, 4H (H-2)), 2.91 (ddd, J = 12.9, 8.3, 6.5 Hz, 1H), 2.82 (ddd,
J = 12.9, 8.4, 7.0 Hz, 1H). 13C{1H} NMR (126 MHz, CDCl3): δ
165.8, 165.7, 165.3, 162.0, 161.8, 138.8, 138.6, 138.0, 133.3, 133.0,
129.9, 129.6, 129.2, 129.1, 128.9, 128.36, 128.33, 128.29, 128.23,
128.21, 128.17, 128.0, 127.9, 127.6, 127.5, 127.40, 127.38, 100.8, 97.1
(C-1), 96.6 (C-1′), 90.93 81.5 (C-3), 81.0 (C-2), 77.4 (C-4), 75.3,
74.7, 73.4, 72.2 (C-2′), 71.0, 70.6 (C-3′), 70.3 (C-5), 69.7 (C-4′),
68.4 (C-5′), 68.3 (C-6), 66.8 (C-6′), 56.0, 55.6, 55.3, 33.9. HRMS
(ESI-TOF) (m/z): [M + Na]+ calcd for C66H68O17SNa, 1187.4075;
found, 1187.4118.
Methyl 3,4,6-Tri-O-benzyl-2-O-(2-(benzenethio)ethyl)-α/β-D-gal-
actopyranosyl-(1→6)-2,3,4-O-tribenzoyl-α-D-glucopyranoside (26).
Using general procedure E starting from galactosyl donor 11b (65 mg,
0.112 mmol), silica gel ﬂash column chromatography (0% to 20%
Et2O in toluene) aﬀorded 26 as an anomeric mixture (61 mg, 0.062
mmol, 55%). TLC (Et2O/toluene, 30/70 v/v): Rf = 0.50.
1H NMR
(500 MHz, CDCl3): δ 8.13−7.79 (m, 6H), 7.54−7.06 (m, 29H), 6.12
(t, J = 9.8 Hz, 1H), 5.52 (t, J = 9.9 Hz, 1H), 5.28−5.22 (m, 1H), 5.13
(d, J = 3.5 Hz, H-1′), 4.94−4.86 (m, H, H-1), 4.76 (dd, J = 11.9, 3.6
Hz, 1H), 4.68 (d, J = 11.9 Hz, 1H), 4.55 (t, J = 11.3 Hz, 1H), 4.34
(dt, J = 12.0 Hz, 3H), 3.99 (t, J = 6.4 Hz, 1H), 3.86 (m, 6H), 3.65 (d,
J = 11.1 Hz, 1H), 3.52−3.39 (m, 2H), 3.36 (m, 3H), 3.11 (m, 2H).
13C{1H} NMR (126 MHz, CDCl3): δ 165.8, 165.3, 138.73, 138.66,
138.1, 133.3, 133.0, 129.9, 129.8, 129.7, 129.29, 129.27, 129.1, 129.0,
128.9, 128.39, 128.36, 128.33, 128.29, 128.25, 128.21, 127.7, 127.6,
127.54, 127.50, 127.45, 97.7 (C-1), 96.8 (C-1′), 78.2, 77.4, 75.0, 74.8,
73.2, 72.8, 72.1, 70.7, 70.1, 69.6, 69.3, 68.6, 68.4, 66.7, 55.5. HRMS
(ESI-TOF) (m/z): [M + Na]+ calcd for C63H62O15SNa, 1113.3707;
found, 1113.3652.
Methyl 3,4,6-Tri-O-benzyl-2-O-(2-(4-methoxybenzenethio)ethyl)-
α/β-D-galactopyranosyl-(1→6)-2,3,4-O-tribenzoyl-α-D-glucopyra-
noside (27). Using general procedure E and galactosyl donor 12b (50
mg, 0.081 mmol), silica gel ﬂash column chromatography (0% to 25%
Et2O in toluene) aﬀorded 27 as an anomeric mixture (32 mg, 0.029
mmol 36%). TLC (Et2O/toluene, 50/50 v/v): Rf = 0.64.
1H NMR
(500 MHz, CDCl3): δ 8.03−7.81 (m, 6H), 7.55−7.10 (m, 26H), 6.76
(d, J = 8.6 Hz, 2H), 6.13 (m, 1H), 5.53 (t, J = 9.9 Hz, 1H), 5.24 (td, J
= 10.2, 3.5 Hz, 2H), 5.13 (d, J = 3.5 Hz, H-1′), 4.95−4.85 (m, 1H, H-
1), 4.76 (m, 1H), 4.67 (m, 1H), 4.54 (d, J = 11.3 Hz, 1H), 4.43−4.24
(m, 3H), 3.99 (t, J = 6.4 Hz, 1H), 3.93−3.84 (m, 4H), 3.84−3.71 (m,
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6H), 3.67 (d, J = 10.3 Hz, 2H), 3.45 (m, 2H), 3.38 (m, 3H), 3.00 (m,
2H). 13C{1H} NMR (126 MHz, CDCl3): δ 165.8, 165.4, 159.0, 138.8,
138.7, 138.1, 133.4, 133.3, 133.0, 132.7, 129.9, 129.8, 129.7, 129.30
129.1, 129.0, 128.40, 128.36, 128.32, 128.26, 128.21, 128.20, 127.7,
127.6, 127.54, 127.49, 127.4, 114.6, 97.8 (C-1), 96.8 (C-1′), 78.2,
77.3, 75.1, 74.8, 73.2, 72.8, 72.1, 70.7, 70.2, 69.6, 69.3, 68.7, 68.4,
66.7, 55.5, 55.3, 35.3. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C64H64O15SNa, 1127.3863; found, 1127.3816.
Methyl 3,4,6-Tri-O-benzyl-2-O-(2-(2,6-dimethoxybenzenethio)-
ethyl)-α-D-galactopyranosyl-(1→6)-2,3,4-O-tribenzoyl-α-D-gluco-
pyranoside (28). Using general procedure E and galactosyl donor 13b
(60 mg, 0.092 mmol), silica gel ﬂash column chromatography (0% to
25% Et2O in toluene) aﬀorded 28 as an anomeric mixture (39 mg,
0.034 mmol 37%). TLC (EtOAc/n-heptane, 50/50 v/v): Rf = 0.68.
1H NMR (500 MHz, CDCl3): δ 8.01−7.81 (m, 6H), 7.53−7.12 (m,
25H), 6.47 (d, J = 8.4 Hz, 2H), 6.11 (t, J = 9.8 Hz, H-3′), 5.45 (t, J =
9.9 Hz, H-4′), 5.23 (dd, J = 10.2, 3.6 Hz, H-2′), 5.11 (d, J = 3.5 Hz,
H-1′), 4.92 (d, J = 3.2 Hz, H-1), 4.87 (d, J = 11.4 Hz, 1H), 4.74 (d, J
= 12.1 Hz, 1H), 4.63 (d, J = 12.0 Hz, 1H), 4.52 (d, J = 11.3 Hz, 1H),
4.42−4.32 (dd, 2H), 4.30 (t, J = 9.3 Hz, H-5′), 4.01 (t, J = 6.5 Hz, H-
5), 3.92−3.83 (m, H-2, H-4, H-6a′), 3.83−3.62 (m, 8H, H-3, H-6b′),
3.45 (t, J = 6.1 Hz, H-6a, H-6b), 3.33 (s, 3H), 3.06−2.87 (m, 2H).
13C{1H} NMR (126 MHz, CDCl3): δ 165.8, 165.4, 161.1, 138.9,
138.7, 138.1, 133.3, 133.0, 129.93, 129.86, 129.6, 129.3, 129.2, 128.9,
128.40, 128.37, 128.27, 128.25, 128.20, 128.18, 127.7, 127.6, 127.5,
127.43, 127.35, 104.0, 97.7 (C-1), 96.7 (C-1′), 78.2 (C-3), 77.5 (C-
2), 75.2 (C-4), 74.8, 73.2, 72.8, 72.1 (C-2′), 71.2, 70.7 (C-3′), 69.7
(C-4′), 69.2 (C-5), 68.6 (C-6), 68.3 (C-5′), 66.7 (C-6′), 56.1, 55.4,
33.4. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for C65H66O16SNa,
1157.3969; found, 1157.3926.
M e t h y l 3 , 4 , 6 - T r i - O - b e n z y l - 2 - O - ( 2 - ( 2 , 4 , 6 -
trimethoxybenzenethio)ethyl)-α-D-galactopyranosyl-(1→6)-2,3,4-
O-tribenzoyl-α-D-glucopyranoside (29). Using general procedure E
and galactosyl donor 14b (44 mg, 0.065 mmol), silica gel ﬂash
column chromatography (0% to 30% EtOAc in n-heptane) aﬀorded
29(45 mg, 0.039 mmol, 59%). TLC (EtOAc/n-heptane, 50/50 v/v):
Rf = 0.64.
1H NMR (400 MHz, CDCl3): δ 8.02−7.80 (m, 6H), 7.54−
7.21 (m, 24H), 6.14−6.01 (m, 2H, H-3′), 5.48−5.41 (m, H-4′), 5.23
(dd, J = 10.2, 3.7 Hz, H-2′), 5.12 (t, J = 3.8 Hz, H-1′), 4.94 (d, J = 3.3
Hz, H-1), 4.88 (d, J = 11.4 Hz, 1H), 4.75 (d, J = 12.0 Hz, 1H), 4.63
(d, J = 12.0 Hz, 1H), 4.53 (d, J = 11.4 Hz, 1H), 4.43−4.27 (m, 2H,
H-5′), 4.01 (t, J = 6.7 Hz, H-5), 3.91−3.77 (m, 3H, H-2, H-3, H-4, H-
6′), 3.77−3.63 (m, 8H, H2−6′), 3.45 (dd, J = 6.5, 3.4 Hz, H2−6),
3.32 (s, 3H), 3.02−2.71 (m, 2H). 13C{1H} NMR (101 MHz, CDCl3):
δ 165.79, 165.76, 165.4, 162.1, 161.8, 138.9, 138.8, 138.1, 133.3,
133.0, 130.0, 129.9, 129.7, 129.3, 129.2, 128.9, 128.41, 128.38, 128.28,
128.26, 128.24, 128.20, 127.7, 127.6, 127.51, 127.45, 127.36, 97.8 (C-
1), 96.7 (C-1′), 90.9, 78.2 (C-3), 77.6 (C-2), 75.2 (C-4), 74.8, 73.2,
72.8, 72.1 (C-2′), 71.2, 70.7 (C-3′), 69.7 (C-4′), 69.2 (C-5), 68.7 (C-
6), 68.3 (C-5′), 66.7 (C-6′), 56.0, 55.41, 55.35. HRMS (ESI-TOF)
(m/z): [M + Na]+ calcd for C66H68O17SNa, 1187.4074; found,
1187.4038.
Methy l 3 ,4 ,6 -T r i -O- (4 -ch lo robenzy l ) -2 -O- (2 - (2 ,4 ,6 -
trimethoxyphenylthio)ethyl)-α-D-glucopyranosyl-(1→6)-2,3,4-tri-
O-benzoyl-α-D-glucopyranoside (30). Using general procedure E
starting from glucosyl donor 15b (67 mg, 0.086 mmol), the crude
product was puriﬁed by silica gel ﬂash column chromatography (20%
to 60% EtOAc in n-heptane), yielding 30 as an anomeric mixture (α/
β = 7.5/1, 82 mg, 75%). TLC (Et2O/toluene 20/80 v/v): Rf = 0.61.
1H NMR (500 MHz, CDCl3): δ 8.00−7.95 (m, 2H), 7.93−7.90 (m,
2H), 7.87−7.83 (m, 2H), 7.55−7.14 (m, 22H), 6.99 (d, J = 8.4 Hz,
2H), 6.16−6.07 (m, 3H, H-3′), 5.47 (dd, J = 10.3, 9.5 Hz, 1H, H-4′),
5.23 (dd, J = 10.1, 3.7 Hz, 1H, H-2′), 5.17 (d, J = 3.6 Hz, 1H, H-1′),
4.93 (d, J = 3.4 Hz, 1H, H-1), 4.82 (d, J = 11.3 Hz, 1H), 4.68 (d, J =
11.5 Hz, 1H), 4.58 (d, J = 11.3 Hz, 1H), 4.51 (d, J = 12.3 Hz, 1H),
4.35 (d, J = 11.5 Hz, 1H), 4.34−4.29 (m, 1H, H-5′), 4.32 (d, J = 12.4
Hz, 1H), 3.91−3.74 (m, 12H, H-3, H-5, H-6a′), 3.72−3.55 (m, 4H,
H-6a, H-6b′), 3.53 (dd, J = 10.1, 8.9 Hz, 1H, H-4), 3.48 (dd, J = 10.7,
2.1 Hz, 1H, H-6b), 3.42 (s, 3H), 3.38 (dd, J = 9.7, 3.5 Hz, 1H, H-2),
2.90 (ddd, J = 12.9, 9.0, 5.8 Hz, 1H), 2.81 (ddd, J = 13.0, 9.1, 5.9 Hz,
1H). 13C{1H} NMR (126 MHz, CDCl3): δ 165.8, 165.7, 165.3, 162.1,
161.8, 137.3, 136.9, 136.3, 133.5, 133.4, 133.20, 133.16, 133.0, 129.90,
129.87, 129.6, 129.21, 129.17, 129.14, 129.0, 128.8, 128.51, 128.48,
128.39, 128.38, 128.37, 128.36, 128.2, 100.8, 96.9 (C-1), 96.7 (C-1′),
91.0, 81.3 (C-3), 81.0 (C-2), 77.3 (C-4), 74.4, 73.7, 72.6, 72.2 (C-2′),
70.8, 70.5 (C-3′), 70.1 (C-5), 69.6 (C-4′), 68.4 (C-5′), 68.3 (C-6),
66.7 (C-6′), 56.1, 55.5, 55.4, 34.0. HRMS (ESI-TOF) (m/z): [M +
Na]+ calcd for C66H65Cl3O17SNa, 1289.2906; found, 1289.2888.
Methy l 3 ,4 ,6 -T r i -O - (4 - cyanobenzy l ) -2 -O- (2 - (2 ,4 ,6 -
trimethoxybenzenethio)ethyl)-α-D-glucopyranosyl-(1→6)-2,3,4-O-
tribenzoyl-α-D-glucopyranoside (31). Using general procedure E
starting from glucosyl donor 19b (56 mg, 0.078 mmol), silica gel ﬂash
column chromatography (0% to 60% EtOAc in n-heptane) aﬀorded
product 31 (64 mg, 0.05 mmol, 65%). TLC (Et2O/toluene, 40/60 v/
v): Rf = 0.36.
1H NMR (500 MHz, CDCl3): δ 8.01−7.18 (m, 27H),
6.12 (d, J = 12.3 Hz, 2H, H-3′), 5.51 (t, J = 9.9 Hz, H-4′), 5.23 (dd, J
= 10.2, 3.7 Hz, H-2′), 5.19 (d, J = 3.6 Hz, H-1′), 5.00 (d, J = 12.5 Hz,
1H), 4.97 (d, J = 3.4 Hz, H-1), 4.82 (d, J = 12.8 Hz, 1H), 4.67 (d, J =
12.6 Hz, 1H), 4.56 (d, J = 13.6 Hz, 2H), 4.44 (d, J = 13.2 Hz, 1H),
4.35−4.29 (m, H-5′), 3.95−3.84 (m, H-3, H-5, H-6a′), 3.80 (d, J =
20.3 Hz, 9H), 3.75−3.52 (m, 2H, H-4, H-6b′, H-6a, H-6b)), 3.44 (s,
H-2), 2.92−2.78 (m, 2H). 13C{1H} NMR (126 MHz, CDCl3): δ
165.9, 165.8, 165.3, 162.0, 161.9, 144.2, 143.8, 143.4, 133.5, 133.1,
132.2, 132.14, 132.05, 129.9, 129.8, 129.6, 129.2, 129.0, 128.9, 128.45,
128.41, 128.3, 127.8, 127.6, 127.2, 118.8, 118.7, 118.6, 111.5, 111.4,
111.2, 100.9, 96.82 (C-1′), 96.81 (C-1), 91.0, 81.6 (C-3), 81.0 (C-2),
77.7 (C-4), 74.1, 73.5, 72.4, 72.1 (C-2′), 70.6, 70.5 (C-3′), 69.9 (C-
5), 69.5 (C-4′), 69.0 (C-6), 68.5 (C-5′), 66.7 (C-6′), 60.4, 56.1, 55.6,
55.4, 34.2. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C69H65N3O17SNa, 1262.3932; found, 1262.3966.
Methyl 3,4,6-Tri-O-(2,4-dichlorobenzyl)-2-O-(2-(2,4,6-
trimethoxyphenylthio)ethyl)-α-D-glucopyranosyl-(1→6)-2,3,4-tri-
O-benzoyl-α-D-glucopyranoside (32). Using general procedure E
starting from glucosyl donor 25b (51 mg, 0.058 mmol), the crude
product was puriﬁed by silica gel ﬂash column chromatography (0%
to 30% EtOAc in n-heptane), yielding 32 as an anomeric mixture (α/
β = 9/1, 69 mg, 81%). TLC (EtOAc/n-heptane, 40/60 v/v): Rf =
0.40. 1H NMR (500 MHz, CDCl3): δ 8.00−7.95 (m, 2H), 7.94−7.89
(m, 2H), 7.88−7.83 (m, 2H), 7.54−7.45 (m, 2H), 7.45−7.27 (m,
12H), 7.25−7.08 (m, 6H), 6.14 (t, J = 9.8 Hz, 1H, H-3′), 6.09 (s,
2H), 5.48 (dd, J = 10.3, 9.5 Hz, 1H, H-4′), 5.24 (dd, J = 10.2, 3.7 Hz,
1H, H-2′), 5.19 (d, J = 3.7 Hz, 1H, H-1′), 4.96 (d, J = 3.4 Hz, 1H, H-
1), 4.90 (d, J = 12.9 Hz, 1H), 4.76 (d, J = 13.1 Hz, 1H), 4.67 (d, J =
12.9 Hz, 1H), 4.59 (d, J = 13.2 Hz, 1H), 4.52 (d, J = 13.1 Hz, 1H),
4.42 (d, J = 13.3 Hz, 1H), 4.35 (ddd, J = 9.8, 7.2, 2.0 Hz, 1H, H-5′),
3.94−3.82 (m, 3H, H-5, H-3, H-6a′), 3.81 (s, 3H), 3.78 (s, 6H), 3.71
(dd, J = 10.9, 2.0 Hz, 1H, H-6b′), 3.69−3.52 (m, 5H, H-4, H-6), 3.46
(s, 3H), 3.42 (dd, J = 9.7, 3.4 Hz, 1H, H-2), 2.84 (dddd, J = 40.2,
12.9, 9.2, 5.8 Hz, 2H). 13C{1H} NMR (126 MHz, CDCl3): δ 165.9,
165.8, 165.3, 162.0, 161.9, 135.1, 134.9, 134.3, 133.8, 133.47, 133.46,
133.41, 133.38, 133.35, 133.2, 133.1, 132.6, 130.0, 129.93, 129.89,
129.86, 129.7, 129.2, 129.1, 129.04, 129.03, 128.83, 128.81, 128.80,
128.42, 128.40, 128.3, 127.0, 126.87, 126.86, 100.7, 96.9 (C-1), 96.8
(C-1′), 91.0, 81.6 (C-3), 81.0 (C-2), 77.5 (C-4), 72.2 (C-2′), 71.4,
71.0, 70.9, 70.6 (C-3′), 70.0 (C-5), 69.8, 69.6 (C-4′), 68.9 (C-6), 68.5
(C-5′), 66.8 (C-6′), 56.1, 55.6, 55.4, 33.9. HRMS (ESI-TOF) (m/z):
[M + Na]+ calcd for C66H62Cl6O17SNa, 1391.1737; found, 1391.1701.
Methy l 3 ,4 ,6 -T r i -O - (4 -ch lo robenzy l ) -2 -O- (2 - (2 ,4 ,6 -
trimethoxybenzenethio)ethyl)-α-D-galactopyranosyl-(1→6)-2,3,4-
O-tribenzoyl-α-D-glucopyranoside (33). Using general procedure E
starting from galactosyl donor 17b (50 mg, 0.064 mmol), silica gel
ﬂash column chromatography (0% to 40% EtOAc in n-heptane)
aﬀorded 33 (27 mg, 0.021 mmol, 33%). TLC (EtOAc/n-heptane, 60/
40 v/v): Rf = 0.75.
1H NMR (500 MHz, CDCl3): δ 8.08−7.82 (m,
6H), 7.55−7.05 (m, 21H), 6.10 (m, 2H, H-3′), 5.49 (t, J = 9.9 Hz, H-
4′), 5.23 (dd, J = 10.2, 3.7 Hz, H-2′), 5.15 (d, J = 3.6 Hz, H-1′), 4.95
(d, J = 3.3 Hz, H-1), 4.79 (d, J = 11.6 Hz, 1H), 4.74 (d, J = 12.1 Hz,
1H), 4.58 (d, J = 12.1 Hz, 1H), 4.45 (d, J = 11.6 Hz, 1H), 4.37 (d, J =
12.1 Hz, 1H), 4.33−4.24 (m, 1H, H-5′), 3.99 (t, J = 6.7 Hz, H-5),
3.89−3.73 (m, 9H, H-2, H-3, H-4, H-6a′), 3.72−3.63 (m, 2H, H-6b′),
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3.46−3.37 (m, H-6a, H-6b), 2.94−2.78 (m, 2H). 13C{1H} NMR (126
MHz, CDCl3): δ 165.82, 165.75, 165.4, 162.1, 161.8, 137.3, 137.1,
136.5, 133.44, 133.35, 133.32, 133.12, 133.05, 129.9, 129.8, 129.6,
129.32, 129.25, 129.1, 129.03, 128.92, 128.88, 128.7, 128.6, 128.43,
128.38, 128.36, 128.3, 128.2, 125.3, 97.7 (C-1), 96.8 (C-1′), 90.9,
78.1 (C-3), 77.6 (C-2), 75.5 (C-4), 74.0, 72.5, 72.2, 72.1 (C-2′), 71.0,
70.6 (C-3′), 69.6 (C-4′), 69.0 (C-5), 68.6 (C-6), 68.3 (C-5′), 66.7
(C-6′), 56.1, 55.41, 55.36, 34.1. HRMS (ESI-TOF) (m/z): [M +
Na]+ calcd for C66H65Cl3O17SNa, 1289.2905; found, 1289.2852.
Methy l 3 ,4 , 6 -T r i -O - (4 - cyanobenzy l ) - 2 -O- (2 - (2 ,4 ,6 -
trimethoxybenzenethio)ethyl)-α-D-galactopyranosyl-(1→6)-2,3,4-
O-tribenzoyl-α-D-glucopyranoside (34). Using general procedure E
starting from galactosyl donor 20b (60 mg, 0.08 mmol), silica gel ﬂash
column chromatography (0% to 40% EtOAc in n-heptane) aﬀorded
34 as an anomeric mixture (86 mg, 0.069 mmol, 87%). TLC (EtOAc/
n-heptane, 60/40 v/v): Rf = 0.51.
1H NMR (500 MHz, CDCl3): δ
8.02−7.78 (m, 6H), 7.66−7.24 (m, 21H), 6.11 (m, 2H, H-3′), 5.54
(t, J = 9.9 Hz, H-4′), 5.24 (dd, J = 10.2, 3.6 Hz, H-2′), 5.17 (d, J = 3.6
Hz, H-1′), 5.02 (d, J = 2.9 Hz, H-1), 4.95 (m, 2H), 4.72 (d, J = 13.1
Hz, 1H), 4.56 (d, J = 12.6 Hz, 1H), 4.44 (d, J = 13.1 Hz, 1H), 4.37
(d, J = 13.1 Hz, 1H), 4.29 (ddd, J = 10.1, 6.1, 2.0 Hz, H-5′), 4.07 (t, J
= 6.6 Hz, H-5), 3.96−3.86 (m, H-2, H-3, H-4, H-6a′), 3.82 (s, 3H),
3.77 (s, 6H), 3.75−3.60 (m, 2H, H-6b′), 3.56−3.45 (m, H-6a, H-6b).
13C{1H} NMR (126 MHz, CDCl3): δ 165.9, 165.8, 165.4, 162.0,
161.9, 144.3, 143.9, 143.4, 133.43, 133.42, 133.1, 132.3, 132.14,
132.10, 129.9, 129.8, 129.6, 129.2, 129.0, 128.9, 128.5, 128.4, 128.3,
127.8, 127.5, 127.4, 118.8, 118.7, 111.5, 111.4, 111.2, 100.9, 97.6 (C-
1), 96.9 (C-1′), 91.0, 78.5 (C-3), 77.7 (C-2), 76.7 (C-4), 74.0, 72.5,
72.2, 72.0 (C-2′), 70.58, 70.55 (C-3′), 69.5 (C-4′), 69.1 (C-6), 68.9
(C-5), 68.3 (C-5′), 66.7 (C-6′), 56.1, 55.5, 55.4, 34.3. HRMS (ESI-
TOF) (m/z): [M + Na]+ calcd for C69H65N3O17SNa, 1262.3932;
found, 1262.3873.
Methyl 3,4,6-Tri-O-(2,4-dichlorobenzyl)-2-O-(2-(2,4,6-
trimethoxythiophenyl)ethyl)-α-D-galactopyranosyl-(1→6)-2,3,4-O-
tribenzoyl-α-D-glucopyranoside (35). Using general procedure E
starting from galactosyl donor 18b (50 mg, 0.057 mmol), silica gel
ﬂash column chromatography (0% to 40% EtOAc in n-heptane)
aﬀorded 35 as an anomeric mixture (53 mg, 0.039 mmol, 68%). TLC
(EtOAc/n-heptane, 50/50 v/v): Rf = 0.5.
1H NMR (500 MHz,
CDCl3): δ 7.94−7.72 (m, 6H), 7.48−6.93 (m, 18H), 6.11−5.99 (m,
2H, H-3′), 5.33 (t, J = 9.9 Hz, H-4′), 5.16 (dd, J = 10.2, 3.7 Hz, H-
2′), 5.12 (d, J = 9.9 Hz, 1H), 5.04 (d, J = 3.6 Hz, H-1′), 4.98 (d, J =
10.6 Hz, 1H), 4.81 (s, H-1), 4.72−4.49 (m, 4H), 4.31−4.20 (m, H-
5′), 4.04 (t, J = 6.3 Hz, H-5), 3.94 (s, H-4), 3.83−3.60 (m, 10H, H-2,
H-3, H-6a′, H-6b′, H-6a), 3.54 (td, J = 10.1, 6.0 Hz, 1H), 3.42 (dd, J
= 9.3, 5.4 Hz, H-6b), 2.91−2.64 (m, 2H). 13C{1H} NMR (126 MHz,
CDCl3): δ 165.74, 165.71, 165.4, 162.1, 161.8, 137.2, 136.9, 136.8,
134.2, 134.1, 133.5, 133.30, 133.28, 133.0, 129.92, 129.88, 129.86,
129.7, 129.6, 129.5, 129.3, 129.2, 128.9, 128.4, 128.3, 128.24, 128.23,
128.1, 100.9, 97.9 (C-1), 96.7 (C-1′), 90.9, 79.6 (C-3), 77.5 (C-2),
75.9 (C-4), 72.1 (C-2′), 71.6, 70.7 (C-3′), 69.9 (C-4′), 69.6 (C-5),
68.8, 68.7(C-6), 68.5 (C-5′), 68.3, 67.4, 67.2 (C-6′), 56.4, 55.5, 55.4,
33.z9. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C66H62Cl6O17SNa, 1391.1736; found, 1391.1805.
Methyl 3,4,6-Tri-O-(o,p-dichlorobenzyl)-2-O-(2-(2,4,6-
trimethoxyphenylthio)ethyl)-α-D-glucopyranosyl-(1 → 4)-2,3,6-tri-
O-benzyl-α-D-glucopyranoside (38). Using general procedure E
starting from glucosyl donor 16b (50 mg; 0.057 mmol) using
acceptor 36, the crude product was puriﬁed by silica gel ﬂash column
chromatography (15% to 35% EtOAc in n-heptane), yielding 38 (39.6
mg; 0.025 mmol; 53%) as a mixture of isomers. TLC (EtOAc/n-
heptane, 50/50 v/v): Rf = 0.6.
1H NMR (500 MHz, CDCl3): δ 7.41−
7.00 (m, 57H, CH Ar), 6.09 (s, 1H) 6.01 (s, 2H), 5.70 (d, J = 3.7 Hz,
1H, H-1, 5.34 (dt, J = 5.9, 4.5 Hz, 1H), 5.01 (d, J = 11.2 Hz, 1H),
4.86 (d, J = 13.4 Hz, 1H), 4.79−4.73 (m, 1H), 4.73−4.61 (m, 5H),
4.61−4.41 (m, 9H, H-1′), 4.38−4.23 (m, 3H), 4.08−3.99 (m, 2H),
3.93 (t, J = 9.6 Hz, 1H), 3.90−3.72 (m, 12H), 3.69 (s, 6H), 3.67−
3.47 (m, 5H), 3.47−3.41 (m, 2H), 3.41−3.31 (m, 7H), 3.27 (t, J =
9.0 Hz, 0H), 3.18 (dd, J = 9.6, 3.8 Hz, 0H), 3.13−3.06 (m, 0H),
2.86−2.69 (m, 2H). 13C{1H} NMR (126 MHz, CDCl3): δ 161.9,
139.34−131.95 (m), 131.36−125.97 (m), 102.4, 97.8 (C-1′), 96.2
(C-1), 91.0, 90.9, 82.0, 81.9, 80.83, 80.29, 77.5, 74.5, 73.4, 73.2, 71.6,
71.5, 71.4, 71.1, 70.5, 69.8, 69.4, 69.0, 68.7, 56.71−54.63 (m), 33.7,
31.9, 30.2, 22.7, 14.1. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C66H68O14SCl6Na, 1349.2359; found, 1349.2361.
Methyl 3,4,6-Tri-O-(o,p-dichlorobenzyl)-2-O-(2-(2,4,6-
trimethoxyphenylthio)ethyl)-α-D-galactopyranosyl-(1 → 4)-2,3,6-
tri-O-benzyl-α-D-glucopyranoside (39). Using general procedure E
starting from galactosyl donor 18b (25 mg; 0.028 mmol) using
acceptor 36, the crude product was puriﬁed by silica gel ﬂash column
chromatography (0% to 30% EtOAc in n-heptane) yielding 39 (18
mg; 0.014 mmol; 48%). TLC (EtOAc/n-heptane, 50/50 v/v): Rf =
0.6. 1H NMR (500 MHz, CDCl3): δ 7.39−7.04 (m, 24H), 6.01 (s,
2H), 5.75 (d, J = 3.8 Hz, 1H (H-1)), 4.98 (d, J = 11.1 Hz, 1H), 4.83
(d, J = 12.9 Hz, 1H), 4.79 (d, J = 11.2 Hz, 1H), 4.68 (dd, J = 12.6, 5.9
Hz, 2H), 4.62 (d, J = 13.6 Hz, 1H), 4.59−4.52 (m, 4H (H-1′)), 4.47
(d, J = 12.3 Hz, 1H), 4.28 (d, J = 12.8 Hz, 1H), 4.21 (d, J = 12.9 Hz,
1H), 4.05 (t, J = 9.0 Hz, 1H), 3.98−3.91 (m, 2H), 3.90−3.66 (m,
17H), 3.66−3.57 (m, 2H), 3.56−3.49 (m, 2H), 3.44−3.39 (m, 1H),
3.36 (s, 3H), 2.79 (dddd, J = 35.0, 12.8, 9.9, 5.7 Hz, 2H). 13C{1H}
NMR (126 MHz, CDCl3): δ 161.9, 161.7, 138.8, 138.2, 138.0, 134.9,
134.8, 134.2, 133.9, 133.7, 133.51, 133.48, 133.1, 132.8, 130.1, 129.9,
129.5, 129.1, 128.9, 128.4, 128.3, 128.22, 128.16, 127.9, 127.5, 127.4,
127.2, 127.1, 126.93, 126.91, 100.9, 97.7 (C-1′), 97.0 (C-1), 90.9,
81.9, 80.3, 79.0, 75.6, 74.4, 73.3, 73.2, 72.2, 72.0, 71.2, 69.7, 69.4,
69.3, 68.6, 56.0, 55.3, 55.1, 33.8. HRMS (ESI-TOF) (m/z): [M +
Na]+ calcd for C66H68O14SCl6Na, 1351.2362; found, 1351.2329
Pheny l 3 ,4 ,6 -Tr i (o ,p-d ich lorobenzy l ) -2 -O- (2- (2 ,4 ,6 -
trimethoxyphenylthio)ethyl)-α-D-glucopyranosyl-(1 → 2)-4,6-O-
benzylidene-3-O-(2-methylnaphthyl)-1-thio-α-D-mannopyranoside
(40). Using general procedure E starting from glucosyl donor 16b (39
mg; 0.045 mmol) using acceptor 37, the crude product was puriﬁed
by silica gel ﬂash column chromatography (0% to 30% EtOAc in n-
heptane), yielding 40 (31 mg; 0.023 mmol; 52%). TLC: (EtOAc/n-
heptane, 50/50 v/v): Rf = 0.7.
1H NMR (500 MHz, CDCl3): δ 7.89−
7.69 (m, 4H), 7.57−7.33 (m, 12H), 7.32−7.19 (m, 7H), 7.19−7.08
(m, 3H), 6.03 (s, 2H), 5.72 (s, 1H), 5.63 (d, J = 1.5 Hz, 1H, H-1′),
5.42 (d, J = 3.7 Hz, 1H, H-1), 5.03 (d, J = 12.8 Hz, 1H), 4.92 (d, J =
12.4 Hz, 1H), 4.85 (d, J = 12.3 Hz, 1H), 4.78 (dd, J = 12.7, 4.6 Hz,
2H), 4.59−4.46 (m, 2H), 4.46−4.36 (m, 2H, H-4′), 4.37−4.25 (m,
2H, H-2′, H-5′), 4.22 (ddd, J = 9.3, 4.9, 2.1 Hz, 1H, H-6a′), 4.04 (dd,
J = 9.8, 2.9 Hz, 1H, H-3′), 3.94 (m, 2H, H-3, H-6b′), 3.89−3.78 (m,
2H, H-5), 3.74 (s, 3H), 3.71−3.63 (m, 7H, H-6a), 3.59−3.50 (m, 3H,
H-4, H-6b), 3.45 (dd, J = 9.6, 3.7 Hz, 1H, H-2), 2.87 (ddd, J = 13.6,
7.8, 6.1 Hz, 1H), 2.80 (ddd, J = 13.3, 7.9, 6.0 Hz, 1H). 13C{1H} NMR
(126 MHz, CDCl3): δ 161.9, 161.7, 137.7, 135.6, 135.3, 134.5, 134.3,
133.8, 133.71, 133.65, 133.5, 133.3, 133.2, 133.02, 133.00, 131.6,
130.2, 129.8, 129.7, 129.1, 129.0, 128.94, 128.88, 128.8, 128.2, 128.1,
128.0, 127.7, 127.03, 126.97, 126.9, 126.7, 126.24, 126.16, 126.0,
125.9, 125.8, 101.6, 101.4, 98.4 (C-1), 91.0, 88.2 (C-1′), 81.3 (C-3),
81.0(C-2), 79.0 (C-4′), 77.9 (C-2′), 77.6 (C-4), 75.7 (C-3′), 72.8,
71.5, 71.3, 70.6 (C-5), 70.0, 69.7, 69.1 (C-6), 68.5 (C-6′), 65.6 (C-
5′), 56.0, 55.3, 34.5. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C68H64O13S2Cl6Na, 1387.1849; found, 1387.1788.
Pheny l 3 ,4 ,6 -Tr i (o ,p-d ich lorobenzy l ) -2 -O- (2- (2 ,4 ,6 -
trimethoxyphenylthio)ethyl)-α-D-galactopyranosyl-(1 → 2)-4,6-O-
benzylidene-3-O-(2-methylnaphthyl)-1-thio-α-D-mannopyranoside
(41). Using general procedure E starting from galactosyl donor 18b
(44 mg; 0.050 mmol) using acceptor 38, the crude product was
puriﬁed by silica gel ﬂash column chromatography (0% to 30% EtOAc
in n-heptane) yielding 41 (33 mg; 0.024 mmol; 48%). TLC (EtOAc/
n-heptane, 50/50 v/v): Rf = 0.7.
1H NMR (500 MHz, CDCl3): δ
7.82−7.79 (m, 2H), 7.76 (d, J = 8.4 Hz, 1H), 7.71 (dd, J = 8.1, 1.5
Hz, 1H), 7.54−7.41 (m, 6H), 7.38 (m, 3H), 7.36−7.27 (m, 6H),
7.23−7.16 (m, 5H), 7.13 (dd, J = 8.3, 2.1 Hz, 1H), 7.09 (dd, J = 8.3,
2.1 Hz, 1H), 6.03 (s, 2H), 5.71 (s, 1H), 5.68 (d, J = 1.5 Hz, 1H, H-
1′), 5.45 (d, J = 3.5 Hz, 1H, H-1), 4.97−4.75 (m, 5H), 4.58 (d, J =
12.9 Hz, 1H), 4.45−4.36 (m, 2H, H-4′), 4.35−4.27 (m, 3H, H-2′, H-
5′), 4.24−4.15 (m, 1H, H-6a′), 4.08 (t, J = 6.2 Hz, 1H, H-5), 4.03
(dd, J = 9.8, 2.9 Hz, 1H, H-3′), 3.99−3.87 (m, 4H, H-2, H-3, H-4, H-
6b′), 3.87−3.78 (m, 1H), 3.74 (s, 4H), 3.68 (s, 6H), 3.60 (ddd, J =
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9.9, 7.4, 6.2 Hz, 1H), 3.53 (dt, J = 8.9, 5.7 Hz, 1H, H-6a), 3.51−3.44
(m, 1H, H-6b), 2.95−2.84 (m, 1H), 2.80 (ddd, J = 13.0, 7.4, 6.0 Hz,
1H). 13C{1H} NMR (126 MHz, CDCl3): δ 161.98, 161.68, 137.7,
135.7, 135.1, 134.8, 134.2, 133.8, 133.7, 133.7, 133.6, 133.4, 133.3,
133.0, 131.5, 130.4, 130.3, 129.6, 129.0, 128.93, 128.88, 128.2, 128.1,
128.0, 127.7, 127.5, 127.1, 126.9, 126.6, 126.2, 126.0, 125.9, 125.8,
101., 101.44, 99.2 (C-1), 94.7, 91.0, 88.2 (C-1′), 79.0 (C-4′), 78.2
(C-3), 77.9 (C-2′), 77.5 (C-2), 76.0 (C-4), 75.8 (C-3′), 72.7, 71.2,
70.0, 69.93, 69.86 (C-5), 69.62, 69.59 (C-6), 68.5 (C-6′), 65.6 (C-5′),
56.0, 55.3, 34.7. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C68H64O13S2Cl6Na, 1385.1864; found, 1385.1842.
2,4,6-Trimethoxyphenyl 2,3,4,6-Tetra-O-benzyl-1-thio-β-D-glu-
copyranoside (42). Using general procedure D starting from 10a
(98 mg, 0.155 mmol) using BnBr as the benzylation agent, the crude
product was puriﬁed by silica gel ﬂash column chromatography (0%
to 30% EtOAc in n-heptane), aﬀording 42 as a white solid (81 mg,
73%). TLC (EtOAc/n-heptane, 40/60 v/v): Rf = 0.53.
1H NMR (400
MHz, CDCl3): δ 7.54−7.44 (m, 2H), 7.38−7.14 (m, 19H), 6.10 (s,
2H), 5.15 (d, J = 10.3 Hz, 1H), 4.91 (d, J = 10.9 Hz, 1H), 4.84−4.76
(m, 3H), 4.69 (d, J = 9.7 Hz, 1H, H-1), 4.56 (d, J = 10.9 Hz, 1H),
4.46−4.32 (m, 2H), 3.78 (s, 6H), 3.75 (s, 3H), 3.74−3.55 (m, 4H, H-
2, H-3, H-6), 3.52 (dd, J = 9.8, 8.9 Hz, 1H, H-4), 3.37 (ddd, J = 9.8,
5.6, 1.7 Hz, 1H, H-5). 13C{1H} NMR (101 MHz, CDCl3): δ 162.2,
162.0, 138.67, 138.65, 138.6, 138.2, 128.42, 128.39, 128.3, 128.24,
128.21, 128.0, 127.87, 127.86, 127.7, 127.63, 127.60, 127.5, 99.8, 91.2,
86.9 (C-3), 86.8 (C-1), 82.6 (C-2), 79.8 (C-5), 78.2 (C-4), 75.8, 75.2,
75.0, 73.6, 69.6 (C-6), 56.2, 55.3. HRMS (ESI-TOF) (m/z): [M +
Na]+ calcd for C43H46O8SNa, 745.2811; found, 745.2783.
Methyl 2,3,4,6-Tetra-O-benzyl-1-thio-α/β-D-glucopyranosyl-(1→
6)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (50). Using general
procedure F starting from glucosyl donor 42 (0.40 g; 0.059 mmol),
the crude product was puriﬁed by silica gel ﬂash column
chromatography (10% to 40% EtOAc in n-heptane), yielding 50 as
a mixture of isomers (46.7 mg, 0.045 mmol, 68%). TLC (EtOAc/n-
heptane, 40/60 v/v): Rf = 0.57.
1H NMR (500 MHz, CDCl3): δ
8.01−7.89 (m, 8H), 7.87−7.83 (m, 4H), 7.52−7.45 (m, 4H), 7.45−
7.08 (m, 46H), 6.21−6.16 (m, 1H), 6.14 (t, J = 8.5 Hz, 1H), 5.53
(dd, J = 10.3, 9.5 Hz, 1H), 5.48 (dd, J = 10.3, 9.5 Hz, 1H), 5.28−5.19
(m, 4H), 5.06 (d, J = 10.8 Hz, 1H), 4.91 (d, J = 11.0 Hz, 2H), 4.84−
4.71 (m, 6H, α-H-1), 4.69 (d, J = 10.8 Hz, 1H), 4.63 (d, J = 12.2 Hz,
1H), 4.56−4.42 (m, 6H, β-H-1), 4.41−4.34 (m, 2H), 4.32 (ddd, J =
10.4, 6.6, 2.2 Hz, 1H), 4.13 (dd, J = 11.0, 2.2 Hz, 1H), 3.96 (t, J = 9.3
Hz, 1H), 3.89−3.78 (m, 3H), 3.68−3.40 (m, 13H), 3.38 (s, 3H).
13C{1H} NMR (126 MHz, CDCl3): δ 165.81, 165.80, 165.75, 165.4,
165.2, 138.9, 138.59, 138.56, 138.5, 138.4, 138.10, 138.07, 137.9,
133.4, 133.3, 133.04, 133.03, 129.91, 129.88, 129.66, 129.64, 129.3,
129.2, 129.08, 129.06, 129.0, 128.9, 128.4−128.3 (m), 128.3−128.15
(m), 127.9, 127.91, 127.89, 127.85, 127.8, 127.72, 127.65, 127.62,
127.56, 127.54, 127.47, 127.46, 104.0 (β-C-1), 97.2 (α-C-1), 96.8,
96.7, 84.5, 82.3, 81.7, 80.0, 77.7, 77.6, 75.7, 75.7, 75.5, 75.00, 74.96,
74.9, 74.80, 74.77, 73.5, 73.42, 73.39, 73.3, 73.1, 72.2, 72.1, 70.6, 70.5,
70.2, 69.9, 69.6, 69.0, 68.9, 68.64, 68.56, 68.3, 66.6, 55.6, 55.5. HRMS
(ESI-TOF) (m/z): [M + Na]+ calcd for C62H60O14Na, 1051.3881;
found, 1051.3851.
2,4,6-Trimethoxyphenyl 2-O-Benzyl-3,4,6-tri-O-(2,4-dichloroben-
zyl)-1-thio-β-D-glucopyranoside (43). Using general procedure D
starting from 16a (0.074 g, 0.088 mmol) using BnBr as the
benzylation agent, the crude product was puriﬁed by silica gel ﬂash
column chromatography (0% to 30% EtOAc in n-heptane), yielding
43 as a white solid (49 mg, 60%). TLC (EtOAc/n-heptane, 40/60 v/
v): Rf = 0.57.
1H NMR (500 MHz, CDCl3): δ 7.43−7.02 (m, 18H),
6.09 (s, 2H), 5.15 (d, J = 10.4 Hz, 1H), 4.94 (d, J = 13.1 Hz, 1H),
4.80−4.67 (m, 5H, H-1), 4.59 (d, J = 12.7 Hz, 1H), 4.48 (d, J = 12.9
Hz, 1H), 4.39 (d, J = 12.9 Hz, 1H), 3.79 (s, 7H), 3.76 (s, 3H), 3.75−
3.64 (m, 3H, H-6, H-3), 3.63−3.53 (m, 2H, H-2, H-4), 3.38 (ddd, J =
9.9, 5.3, 1.9 Hz, 1H, H-5). 13C{1H} NMR (126 MHz, CDCl3): δ
162.1, 162.0, 138.2, 135.4, 135.0, 134.7, 134.5, 133.8, 133.6, 133.5,
133.3, 133.0, 132.7, 130.4, 130.1, 129.7, 129.4, 128.90, 128.88, 128.8,
128.5, 128.4, 128.3, 128.23, 128.17, 127.7, 126.96, 126.95, 99.5, 91.1,
86.7 (C-1, C-3), 82.4 (C-2), 79.1 (C-5), 78.1 (C-4), 75.1, 71.7, 71.0,
70.0, 56.2, 55.3. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C43H40O8SCl6Na, 949.0473; found, 949.0464.
Methyl 2-O-Benzyl-3,4,6-tri-O-(2,4-dichlorobenzyl)-1-thio-α-D-
glucopyranosyl-(1→6)- 2,3,4-tri-O-benzoyl-α-D-glucopyranoside
(51). Using general procedure F starting from glucosyl donor 43
(0.489 g; 0.053 mmol), the crude product was puriﬁed by silica gel
ﬂash column chromatography (0% to 30% EtOAc in n-heptane),
yielding 51 as a mixture of isomers (α/β = 4/1, 37 mg, 57%). TLC
(EtOAc/n-heptane, 40/60 v/v): Rf = 0.62.
1H NMR (500 MHz,
CDCl3): δ 8.03−7.76 (m, 8H), 7.57−7.07 (m, 30H), 6.21−6.11 (m,
1H, H-3′), 5.60−5.54 (m, 1H, H-4′), 5.28−5.19 (m, 2H, H-1′, H-2′),
5.05 (d, J = 10.9 Hz, 1H), 4.98 (d, J = 12.9 Hz, 1H), 4.94 (d, J = 13.0
Hz, 1H), 4.83−4.66 (m, 5H, H-1), 4.66−4.48 (m, 4H), 4.45 (d, J =
13.4 Hz, 1H), 4.39 (d, J = 13.3 Hz, 1H), 4.33 (ddd, J = 10.3, 6.3, 2.0
Hz, 1H, H-5′), 4.13 (dd, J = 11.0, 2.2 Hz, 1H), 3.99 (t, J = 9.2 Hz,
1H, H-3), 3.91−3.83 (m, 2H, H-5, H-6a′), 3.83−3.73 (m, 1H), 3.72−
3.69 (m, 1H), 3.67−3.50 (m, 6H, H-2, H-4, H-6, H-6b′), 3.47 (s,
3H). 13C{1H} NMR (126 MHz, CDCl3): δ 165.84, 165.81, 165.7,
165.5, 165.2, 138.12, 138.05, 135.1, 135.0, 134.9, 134.5, 134.4, 134.2,
133.8, 133.74, 133.67, 133.52, 133.50, 133.44, 133.37, 133.30, 133.25,
133.22, 133.1, 132.7, 130.2, 129.5, 129.4, 127.7, 127.1, 126.8, 97.0 (C-
1), 96.9 (C-1′), 84.5, 82.0, 81.6 (C-3), 80.0 (C-2), 77.6, 77.5 (C-4),
74.7, 74.6, 73.0, 72.2 (C-2′), 72.1, 71.6, 71.5, 71.1, 71.0, 70.6 (C-3′),
70.4, 70.0 (C-5), 69.9, 69.8, 69.7, 69.5 (C-4′), 69.2, 69.0, 68.9 (C-6),
68.6 (C-5′), 66.6 (C-6′), 55.60, 55.57. HRMS (ESI-TOF) (m/z): [M
+ Na]+ calcd for C62H54O14Cl6Na, 1257.1513; found, 1257.1537.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-benzyl-2-O-propyl-1-thio-β-
D-glucopyranoside (44). Using general procedure D starting from
10a (99 mg, 0.156 mmol) using propyl bromide as the alkylating
agent, the crude product was puriﬁed by silica gel ﬂash column
chromatography (0% to 30% EtOAc in n-heptane), yielding 44 (91
mg, 87%) as a white solid. TLC (EtOAc/n-heptane, 40/60 v/v): Rf =
0.54. 1H NMR (400 MHz, CDCl3): δ 7.38−7.23 (m, 19H), 7.21−
7.12 (m, 4H), 6.10 (s, 2H), 4.94 (d, J = 10.9 Hz, 1H), 4.87−4.75 (m,
2H), 4.63 (d, J = 9.8 Hz, 1H, H-1), 4.53 (d, J = 11.0 Hz, 1H), 4.43−
4.29 (m, 2H), 4.03−3.92 (m, 1H), 3.81 (s, 6H), 3.74 (s, 4H), 3.71
(dd, J = 11.6, 1.8 Hz, 1H, H-6a), 3.64−3.54 (m, 2H, H-3, H-6b),
3.49−3.43 (m, 1H, H-4), 3.41−3.30 (m, 2H, H-2, H-5), 1.68 (h, J =
7.1 Hz, 2H), 0.96 (t, J = 7.4 Hz, 3H). 13C{1H} NMR (101 MHz,
CDCl3): δ 162.1, 128.39, 128.35, 128.2, 127.9, 127.83, 127.82, 127.7,
127.6, 127.4, 91.2, 86.9 (C-3), 86.3 (C-1), 82.7 (C-2), 79.9 (C-5),
78.1 (C-4), 75.7, 75.0, 74.9, 73.6, 69.6 (C-6), 56.2, 55.24 23.6, 10.6.
HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for C39H46O8SNa,
697.2811; found, 697.2786.
Methyl 3,4,6-Tri-O-benzyl-2-O-propyl-1-thio-α-D-glucopyrano-
syl-(1→6)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (52). Using gen-
eral procedure F starting from glucosyl donor 44 (40 mg, 0.059
mmol), the crude product was puriﬁed by silica gel ﬂash column
chromatography (0% to 40% EtOAc in n-heptane), aﬀording 52 as a
mixture of anomers (37 mg, 62%). TLC (EtOAc/n-heptane, 40/60 v/
v): Rf = 0.32.
1H NMR (500 MHz, CDCl3): δ 8.17−7.81 (m, 13H),
7.62−7.10 (m, 38H), 6.14 (t, J = 9.8 Hz, 1H, H-3′), 5.56−5.50 (m,
1H, H-4′), 5.24 (dd, J = 10.1 Hz, 3.7 Hz, 1H, H-2′), 5.18 (d, J = 3.6
Hz, 1H, H-1′), 4.97 (d, J = 3.4 Hz, 1H, H-1), 4.85−4.77 (m, 2H),
4.74 (d, J = 11.0 Hz, 1H), 4.57 (d, J = 12.0 Hz, 1H), 4.45 (d, J = 11.1
Hz, 1H), 4.40 (d, J = 12.1 Hz, 1H), 4.36−4.31 (m, 1H, H-5′), 3.94−
3.84 (m, 4H, H-3, H-6a), 3.71 (dd, J = 11.2, 2.1 Hz, 1H, H-6a′),
3.68−3.49 (m, 5H, H-4, H-6b′, H-6, H-7), 3.48−3.41 (m, 6H), 1.67−
1.56 (m, 2H), 0.98−0.81 (m, 3H). 13C{1H} NMR (126 MHz,
CDCl3): δ 167.4, 167.0, 166.0, 165.9, 165.9, 165.3, 139.0, 138.7,
138.0, 133.43, 133.40, 133.35, 133.33, 133.0, 130.1, 129.8, 129.7, 129.,
129.20, 129.12, 129.10, 129.0, 128.50, 128.46, 128.2, 128.0, 127.9,
127.6, 127.47, 127.45, 97.1 (C-1), 96.8 (C-1′), 81.6 (C-3), 80.7 (C-
2), 77.5 (C-4), 75.4, 74.8, 72.9 (C-2′), 72.2 (C-7), 70.7 (C-3), 70.4,
70.1 (C-4), 69.73 (C-4′), 69.65, 68.7 (C-5′), 68.4 (C-6), 66.6 (C-6′),
55.6, 55.5, 23.3, 10.6. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C58H60O14Na, 1003.3881; found, 1003.3837.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-(2,4-dichlorobenzyl)-2-O-
propyl-1-thio-β-D-glucopyranoside (45). Using general procedure
D starting from 16a (0.10 g, 0.12 mmol) and 1-bromopropane as the
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alkylating agent, the crude product was puriﬁed by silica gel ﬂash
column chromatography (30% to 60% EtOAc in n-heptane), yielding
45 as a white solid (88 mg, 84%). TLC (EtOAc/n-heptane, 40/60 v/
v): Rf = 0.35.
1H NMR (500 MHz, CDCl3): δ 7.41 (d, J = 8.3 Hz,
1H), 7.38−7.02 (m, 8H), 6.08 (s, 2H), 4.98 (d, J = 13.2 Hz, 1H),
4.78 (d, J = 13.3 Hz, 1H), 4.73 (d, J = 12.7 Hz, 1H), 4.67 (d, J = 9.8
Hz, 1H, H-1), 4.57 (d, J = 12.7 Hz, 1H), 4.44 (d, J = 12.9 Hz, 1H),
4.34 (d, J = 12.9 Hz, 1H), 3.97 (dt, J = 8.5, 7.0 Hz, 1H), 3.82 (s, 6H),
3.75 (s, 3H), 3.71 (dd, J = 11.4, 1.9 Hz, 1H, H-6a), 3.66−3.60 (m,
3H, H-3, H-6b), 3.51 (t, J = 9.4 Hz, 1H, H-4), 3.40 (dd, J = 9.8, 8.7
Hz, 1H, H-2), 3.35 (ddd, J = 9.9, 5.5, 1.8 Hz, 1H, H-5), 1.66−1.53
(m, 2H), 0.93−0.85 (m, 3H). 13C{1H} NMR (126 MHz, CDCl3): δ
162.0, 161.9, 135.1, 134.8, 134.5, 133.7, 133.6, 133.4, 133.3, 133.0,
132.7, 130.1, 129.7, 129.3, 128.90, 128.87, 128.8, 127.0, 126.94,
126.92, 91.2, 86.8 (C-3), 86.2 (C-1), 82.7 (C-2), 79.2 (C-5), 78.0 (C-
4), 75.0, 71.6, 70.0 (C-6), 69.9, 56.20, 56.18, 56.15, 55.25, 55.22, 23.5,
10.5. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C39H40Cl6O8SNa, 901.0472; found, 901.0439.
Methyl 3,4,6-Tri-O-(2,4-dichlorobenzyl)-2-O-propyl-1-thio-α/β-D-
glucopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside
(53). Using general procedure F starting from glucosyl donor 45 (50
mg; 0.057 mmol), the crude product was puriﬁed by silica gel ﬂash
column chromatography (10% to 60% EtOAc in n-heptane), yielding
53 as an anomeric mixture (α/β = 3/1, 35 mg, 51%). TLC (EtOAc/n-
heptane, 40/60 v/v): Rf = 0.8. α-Anomer
1H NMR (500 MHz,
CDCl3): δ 7.98−7.71 (m, 6H), 7.51−6.93 (m, 15H), 6.08 (t, J = 9.8
Hz, 1H, H-3′), 5.48 (t, J = 9.9 Hz, 1H, H-4′), 5.18 (dd, J = 10.1, 3.7
Hz, 1H, H-2′), 5.14 (d, J = 3.7 Hz, 1H, H-1′), 4.94−4.89 (m, 2H, H-
1), 4.72 (d, J = 13.1 Hz, 1H), 4.67 (d, J = 13.1 Hz, 1H), 4.53 (d, J =
13.4 Hz, 1H), 4.46 (d, J = 13.1 Hz, 1H), 4.35 (d, J = 13.2 Hz, 1H),
4.30−4.22 (m, 1H, H-5′), 3.91−3.78 (m, 3H, H-3, H-5, H-6′a),
3.71−3.32 (m, 10H, H-6a, H-6′b, H-6b, H-4, H-2), 1.57−1.45 (m,
2H), 0.87−0.76 (m, 3H). 13C{1H} NMR (126 MHz, CDCl3): δ
165.9, 165.8, 165.2, 135.3, 134.9, 134.3, 133.7, 133.48, 133.46, 133.43,
133.39, 133.30, 133.2, 133.1, 132.7, 129.95, 129.94, 129.86, 129.84,
129.82, 129.75, 129.67, 129.64, 129.61, 129.59, 129.3, 129.2, 129.04,
129.01, 128.96, 128.95, 128.92, 128.86, 128.81, 128.5, 128.43, 128.42,
128.32, 128.28, 128.25, 127.02, 126.95, 126.88, 126.86, 96.88 (C-1),
96.85 (C-1′), 81.5 (C-3), 80.7 (C-2), 77.4 (C-4), 72.8, 72.2 (C-2′),
71.4, 71.0, 70.6 (C-3′), 70.1 (C-5′), 69.8, 69.5 (C-4′), 69.0, 68.7(C-
5), 66.6, 55.6, 23.3, 10.5. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd
for C58H54Cl6O14Na, 1207.1504; found, 1207.1568.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-(benzyl)-2-O-(3-hydroxy-
propyl)-1-thio-β-D-glucopyranoside (46). Using general procedure
C starting from 10a (124 mg; 0.192 mmol) using Br(CH2)3OTHP as
the alkylating agent, the crude product was puriﬁed by silica gel ﬂash
column chromatography (10% to 60% EtOAc in n-heptane), yielding
46 as a white solid (84 mg, 62%). TLC (EtOAc/n-heptane, 40/60 v/
v): Rf = 0.25.
1H NMR (500 MHz, CDCl3): δ 7.43−7.08 (m, 15H),
6.11 (s, 2H), 4.91 (d, J = 10.9 Hz, 1H), 4.84 (d, J = 10.9 Hz, 1H),
4.79 (d, J = 10.9 Hz, 1H), 4.57−4.52 (m, 2H, H-1), 4.41 (d, J = 11.7
Hz, 1H), 4.38 (d, J = 11.7 Hz, 1H), 4.07−4.00 (m, 2H), 3.97−3.89
(m, 1H), 3.83 (s, 6H), 3.76 (s, 3H), 3.70 (dd, J = 11.6, 1.7 Hz, 1H, H-
6a), 3.62 (t, J = 8.9 Hz, 1H, H-3), 3.57 (dd, J = 11.6, 5.8 Hz, 1H, H-
6b), 3.46 (t, J = 9.4 Hz, 1H, H-4), 3.34 (dd, J = 10.0, 8.8 Hz, 1H, H-
2), 3.32−3.28 (m, 1H, H-5), 3.09 (t, J = 6.9 Hz, 1H), 1.96−1.84 (m,
1H), 1.82−1.73 (m, 1H). 13C{1H} NMR (126 MHz, CDCl3): δ
162.29, 162.25, 138.51, 138.48, 138.0, 128.43, 128.35, 128.2, 127.9,
127.8, 127.71, 127.69, 127.4, 98.8, 91.2, 87.0 (C-1), 86.7 (C-3), 82.1
(C-2), 79.8 (C-5), 78.0 (C-4), 75.7, 74.9, 73.6, 71.4, 69.6 (C-6), 60.6,
56.2, 55.3, 32.7. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C39H46O9SNa, 713.2728; found, 713.2760.
Methyl 3,4,6-Tri-O-benzyl-2-O-(2-(2,4,6-trimethoxyphenylthio)-
propyl)-1-thio-α/β-D-glucopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-α-
D-glucopyranoside (54). Using general procedure E starting from
glucosyl donor 46 (56 mg, 0.081 mmol), the crude product was
puriﬁed by silica gel ﬂash column chromatography (10% to 40%
EtOAc in n-heptane), yielding 54 as an anomeric mixture (α/β = 2/1,
68 mg, 71%). 1H NMR (500 MHz, CDCl3): δ 7.98−7.71 (m, 10H),
7.50−6.97 (m, 48H), 6.05 (s, 1H), 6.02 (s, 2H), 5.41 (t, J = 9.9 Hz,
1H), 5.35 (t, J = 9.9 Hz, 1H), 5.19−5.13 (m, 2H), 5.11 (d, J = 3.6 Hz,
1H, α-H-1′), 5.10 (d, J = 3.7 Hz, 1H, β-H-1′), 4.86 (d, J = 3.4 Hz, 1H,
α-H-1), 4.83−4.66 (m, 4H), 4.67−4.57 (m, 2H), 4.49 (d, J = 12.0 Hz,
1H), 4.45−4.39 (m, 2H), 4.37 (d, J = 11.0 Hz, 1H), 4.33 (d, J = 12.0
Hz, 1H), 4.30−4.22 (m, 2H, β-H-1), 3.98−3.90 (m, 1H), 3.86−3.75
(m, 4H), 3.74 (s, 2H), 3.72 (s, 3H), 3.70 (s, 3H), 3.70 (s, 9H), 3.69−
3.49 (m, 7H), 3.49−3.39 (m, 3H), 3.37−3.28 (m, 2H), 3.35 (s, 3H),
3.34 (s, 3H), 3.14 (ddd, J = 7.6, 6.3, 2.4 Hz, 1H), 2.77−2.63 (m, 2H),
1.77−1.56 (m, 2H). 13C{1H} NMR (126 MHz, CDCl3): δ 165.75,
165.71, 165.3, 165.2, 162.07, 162.05, 161.57, 161.55, 138.8, 138.6,
138.10, 138.05, 138.0, 133.30, 133.26, 133.21, 132.97, 132.96, 129.85,
129.80, 129.76, 129.6, 129.21, 129.19, 129.1, 128.9, 128.4, 128.33,
128.28, 128.27, 128.24, 128.20, 128.19, 128.15, 127.93, 127.91,
127.84, 127.83, 127.80, 127.65, 127.63, 127.61, 127.55, 127.54,
127.48, 127.46, 127.37, 127.35, 103.9 (β-C-1), 101.6, 101.3, 96.9 (α-
C-1), 96.7 (β-C-1′), 96.6 (α-C-1), 90.94, 90.90, 84.5, 82.5, 81.4, 80.7,
77.5, 77.42, 77.3, 77.0, 76.8, 75.5, 75.3, 74.84, 74.77, 74.7, 73.33,
73.31, 72.2, 72.1, 71.7, 70.6, 70.5, 70.3, 69.8, 69.6, 69.4, 69.0, 68.8,
68.7, 68.4, 68.3, 66.7, 56.04, 56.01, 55.5, 55.4, 55.3, 31.8, 31.3, 30.90,
30.87, 30.4, 29.7, 22.6. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd
for C67H70O17SNa, 1201.4231; found, 1201.4233.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-(2,4-dichlorobenzyl)-2-O-(3-
hydroxypropyl)-1-thio-β-D-glucopyranoside (47). Using general
procedure C starting from 16a (0.100 g, 0.119 mmol) using
Br(CH2)3OTHP as the alkylating agent, the crude product was
puriﬁed by silica gel ﬂash column chromatography (20% to 50%
EtOAc in n-heptane), aﬀording 47 as a white solid (78 mg, 73%).
TLC (EtOAc/n-heptane, 40/60 v/v): Rf = 0.25.
1H NMR (500 MHz,
CDCl3): δ 7.40 (d, J = 8.3 Hz, 1H), 7.31 (dd, J = 14.1, 2.1 Hz, 2H),
7.28−7.23 (m, 5H), 7.22−7.09 (m, 6H), 6.09 (s, 2H), 4.97 (d, J =
13.0 Hz, 1H), 4.79 (d, J = 13.0 Hz, 1H), 4.74 (d, J = 12.8 Hz, 1H),
4.61−4.54 (m, 2H, H-1), 4.47 (d, J = 12.8 Hz, 1H), 4.38 (d, J = 12.9
Hz, 1H), 4.10−4.00 (m, 1H), 3.96−3.85 (m, 2H), 3.85−3.75 (m,
10H), 3.70 (dd, J = 11.4, 2.0 Hz, 1H, H-6a), 3.68−3.59 (m, 2H, H-3,
H-6b), 3.51 (t, J = 9.4 Hz, 1H, H-4), 3.42−3.29 (m, 2H, H-2, H-5),
2.99 (t, J = 6.9 Hz, 1H), 1.92−1.79 (m, 1H), 1.79−1.65 (m, 1H).
13C{1H} NMR (126 MHz, CDCl3): δ 162.4, 162.2, 134.9, 134.7,
134.4, 133.8, 133.66, 133.64, 133.4, 133.0, 132.8, 130.2, 129.6, 129.5,
128.93, 128.92, 127.1, 126.98, 126.95, 98.6, 91.2, 86.9 (C-1), 86.7 (C-
3), 82.1 (C-2), 79.2 (C-5), 78.1 (C-4), 71.6, 71.3, 71.1, 70.02 (C-6),
70.01, 60.4, 56.2, 55.3, 32.7. HRMS (ESI-TOF) (m/z): [M + Na]+
calcd for C39H40O9SCl6Na, 917.0422; found, 917.0403.
Methyl 3,4,6-Tri-O-(2,4-dichlorobenzyl)-2-O-(2-(2,4,6-
trimethoxyphenylthio)propyl)-α/β-D-glucopyranosyl-(1→6)-2,3,4-
tri-O-benzoyl-α-D-glucopyranoside (55). Using general procedure E
starting from glucosyl donor 47 (51 mg, 0.058 mmol), the crude
product was puriﬁed by silica gel ﬂash column chromatography (0%
to 30% EtOAc in n-heptane), aﬀording 55 as a mixture of anomers
(α/β = 2.5/1, 39 mg, 49%). TLC (EtOAc/n-heptane, 40/60 v/v): Rf
= 0.43. 1H NMR (500 MHz, CDCl3): δ 8.03−7.83 (m, 7H), 7.55−
7.08 (m, 22H), 6.18−6.10 (m, 1H, H-3′), 6.09 (s, 2H), 5.52 (t, J =
10.0 Hz, 1H, H-4′), 5.25 (dd, J = 10.1, 3.7 Hz, 1H, H-2′), 5.21 (d, J =
3.7 Hz, 1H, H-1′), 4.97 (d, J = 3.4 Hz, 1H, H-1), 4.90 (d, J = 13.0 Hz,
1H), 4.77 (d, J = 13.0 Hz, 1H), 4.69 (d, J = 13.1 Hz, 1H), 4.59 (d, J =
13.3 Hz, 1H), 4.56−4.50 (m, 1H), 4.42 (d, J = 13.3 Hz, 1H), 4.34
(ddd, J = 10.4, 6.7, 2.0 Hz, 1H, H-5′), 3.96−3.84 (m, 3H, H-3, H-5,
H-6a′), 3.79 (m, 9H), 3.77−3.52 (m, 6H, H-4, H-6, H6b′, H-7), 3.46
(s, 3H), 3.44−3.38 (m, 1H, H-2), 2.84−2.62 (m, 2H), 1.83−1.62 (m,
2H). 13C{1H} NMR (126 MHz, CDCl3): δ 165.9, 165.8, 165.3, 162.1,
161.7, 135.2, 134.9, 134.4, 133.7, 133.5, 133.41, 133.38, 133.3, 133.12,
133.08, 132.7, 129.99, 129.94, 129.85, 129.67, 129.65, 129.3, 129.1,
128.9, 128.84−128.75 (m), 128.42, 128.38, 128.2, 127.0, 126.88,
126.85, 101.2, 96.8 (C-1′), 96.7 (C-1), 91.0, 81.4 (C-3), 80.7 (C-2),
77.4 (C-4), 72.2 (C-2′), 71.3, 71.0, 70.6 (C-3′), 70.1 (C-5), 69.8, 69.6
(C-4′), 69.3, 69.0 (C-6), 68.5 (C-5), 66.7 (C-6′), 56.1, 55.6, 55.3,
30.8, 29.6. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C67H64Cl6O17SNa, 1405.1893; found, 1405.1883.
2,4,6-Trimethoxyphenyl 3,4,6-Tri-O-benzyl-2-O-acetyl-1-thio-β-
D-glucopyranoside (48). To a solution of 10a (58 mg, 0.092
mmol) in pyridine (2 mL) was added acetic anhydride (1 mL). The
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solution was stirred for 4 h at rt before it was concentrated in vacuo.
Silica gel ﬂash column chromatography (0% to 30% EtOAc in n-
heptane) aﬀorded 48 (56 mg, 91%). TLC (EtOAc/n-heptane, 40/60
v/v): Rf = 0.4.
1H NMR (500 MHz, CDCl3): δ 7.34−7.21 (m, 13H),
7.18 (dd, J = 7.5, 2.0 Hz, 2H), 6.09 (s, 2H), 5.04 (dd, J = 10.0, 8.7 Hz,
1H (H-2)), 4.77 (dd, J = 11.0, 4.2 Hz, 2H), 4.67 (d, J = 11.3 Hz, 1H),
4.57−4.54 (m, 2H (H-1)), 4.48 (d, J = 11.8 Hz, 1H), 4.43 (d, J = 11.7
Hz, 1H), 3.77 (d, J = 9.6 Hz, 10H (H-6)), 3.69−3.58 (m, 3H (H-3,
H-4, H-6)), 3.41 (ddd, J = 9.5, 5.3, 1.8 Hz, 1H, H-5). 13C{1H} NMR
(126 MHz, CDCl3): δ 169.5, 162.2, 138.4, 138.2, 137.9, 128.39,
128.37, 128.2, 128.0, 127.85, 127.81, 127.77, 127.7, 127.5, 99.2, 91.2,
85.8 (C-1), 84.7 (C-3), 80.0 (C-5), 78.0 (C-4), 75.2, 75.0, 73.6, 72.9
(C-2), 69.3 (C-6), 56.1, 55.2, 21.1. HRMS (ESI-TOF) (m/z): [M +
Na]+ calcd for C38H42O9SNa, 697.2447; found, 697.2445
Methyl 3,4,6-Tribenzyl-2-O- acetyl-β-D-glucopyranosyl-(1→6)-
2,3,4-O-tribenzoyl-α-D-glucopyranoside (56). Using general proce-
dure F using glycosyl donor 48 (36 mg, 0.52 mmol), silica gel ﬂash
column chromatography (0% to 40% EtOAc in n-heptane) aﬀorded
56 (42 mg, 0.0428 mmol, 83%). TLC (EtOAc/n-heptane, 40/60 v/
v): Rf = 0.5.
1H NMR (500 MHz, CDCl3): δ 7.90 (dd, J = 8.4, 1.4 Hz,
2H), 7.87−7.82 (m, 2H), 7.77 (dd, J = 8.3, 1.4 Hz, 2H), 7.45−7.40
(m, 2H), 7.36−7.12 (m, 20H), 7.08 (dd, J = 7.4, 2.2 Hz, 2H), 6.06 (t,
J = 9.7 Hz, 1H, H-3′), 5.34 (dd, J = 10.3, 9.4 Hz, 1H, H-4′), 5.15 (dd,
J = 10.1, 3.6 Hz, 1H, H-2′), 5.12 (d, J = 3.6 Hz, 1H, H-1′), 4.96 (dd, J
= 9.2, 7.9 Hz, 1H, H-2), 4.70 (dd, J = 11.1, 7.8 Hz, 2H), 4.60 (d, J =
11.4 Hz, 1H), 4.47 (d, J = 2.8 Hz, 1H), 4.44 (d, J = 1.5 Hz, 1H), 4.37
(d, J = 12.2 Hz, 1H), 4.35 (d, J = 8.0 Hz, 1H, H-1), 4.19 (ddd, J = 9.7,
7.3, 1.9 Hz, 1H, H-5′), 3.99 (dd, J = 10.9, 1.9 Hz, 1H, H-6′), 3.65−
3.54 (m, 5H, H-6′, H-6, H-6, H-3, H-4), 3.43−3.34 (m, 4H, H-5),
1.93 (s, 3H). 13C{1H} NMR (126 MHz, CDCl3): δ 169.5, 165.8,
165.7, 165.3, 138.1, 138.0, 137.8, 133.4, 133.3, 133.0, 129.9, 129.8,
129.6, 129.2, 129.0, 128.8, 128.39, 128.37, 128.3, 128.2, 128.0, 127.81,
127.78, 127.70, 127.67, 127.5, 101.3, 96.6 (C-1′), 82.8 (C-3), 77.8
(C-4), 75.2 (C-5), 75.02, 74.99, 73.4, 73.0 (C-2), 72.1 (C-2′), 70.5
(C-3′), 69.5 (C-4′), 68.7 (C-5′), 68.42 (C-6), 68.36 (C-6′), 55.3,
20.9. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for C57H56O12Na,
980.3619; found, 980.3578.
2,4,6-Trimethoxyphenyl 2-O-Acetyl-3,4,6-tri-O-(o,p-dichloroben-
zyl)-1-thio-β-D-glucopyranoside (49). Compound 10a (0.105 g;
0.125 mmol) was dissolved in pyridine (2 mL) and Ac2O (1 mL).
The reaction mixture was stirred at ambient temperature for 4 h,
before it was concentrated in vacuo. Silica gel ﬂash column
chromatography (0% to 30% EtOAc in n-heptane) aﬀorded 49 as a
white solid (76 mg, 69%). TLC (EtOAc/n-heptane, 40/60 v/v): Rf =
0.43. 1H NMR (500 MHz, CDCl3): δ 7.36−7.26 (m, 5H), 7.22−7.10
(m, 4H), 6.09 (s, 2H), 5.07 (dd, J = 10.0, 8.7 Hz, 1H, H-2), 4.78 (d, J
= 13.1 Hz, 1H), 4.75 (d, J = 12.7 Hz, 1H), 4.69 (d, J = 13.0 Hz, 1H),
4.65−4.57 (m, 2H, H-1), 4.52 (d, J = 13.0 Hz, 1H), 4.44 (d, J = 13.0
Hz, 1H), 3.80 (s, 6H), 3.78 (s, 3H), 3.77−3.63 (m, 4H, H-3, H-4, H-
6), 3.43 (ddd, J = 9.6, 4.9, 2.1 Hz, 1H, H-5), 2.02 (s, 3H). 13C{1H}
NMR (126 MHz, CDCl3): δ 169.5, 162.2, 162.1, 134.6, 134.5, 134.2,
134.0, 133.71, 133.66, 133.3, 132.6, 130.1, 129.9, 129.7, 129.0, 128.9,
128.8, 127.2, 127.0, 99.2, 91.2, 85.8 (C-1), 85.1 (C-3), 79.4 (C-5),
77.94 (C-4), 72.88 (C-2), 71.3, 71.2, 70.0, 69.7 (C-6), 56.2, 55.3,
21.1. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C38H36Cl6O9SNa, 901.0109; found, 901.0103.
Methyl 2-O-Acetyl-3,4,6-tri-O-(2,4-dichlorobenzyl)-1-thio-β-D-
glucopyranosyl-(1→6)- 2,3,4-tri-O-benzoyl-α-D-glucopyranoside
(57). Using general procedure F starting from glucosyl donor 49
(51 mg; 0.058 mmol), the crude product was puriﬁed by silica gel
ﬂash column chromatography (10% to 30% EtOAc in n-heptane),
aﬀording 57 (41 mg, 60%). TLC (EtOAc/n-heptane, 40/60 v/v): Rf =
0.57. 1H NMR (500 MHz, CDCl3): δ 8.02−7.95 (m, 2H), 7.95−7.88
(m, 2H), 7.87−7.81 (m, 2H), 7.54−7.47 (m, 2H), 7.44−7.23 (m,
16H), 7.22−7.10 (m, 5H), 6.13 (t, J = 9.7 Hz, 1H, H-3′), 5.42 (dd, J
= 10.3, 9.4 Hz, 1H, H-4′), 5.26−5.16 (m, 2H, H-1′, H-2′), 5.10−5.02
(m, 1H, H-2), 4.78 (d, J = 13.0 Hz, 1H), 4.76 (d, J = 12.5 Hz, 1H),
4.70 (d, J = 12.9 Hz, 1H), 4.62 (d, J = 12.5 Hz, 1H), 4.54 (d, J = 13.4
Hz, 1H), 4.46 (d, J = 7.9 Hz, 1H, H-1), 4.45 (d, J = 13.4 Hz, 1H),
4.25 (ddd, J = 10.3, 7.0, 2.0 Hz, 1H, H-5′), 4.07 (dd, J = 11.0, 2.0 Hz,
1H, H-6a′), 3.77−3.68 (m, 4H, H-3, H-4, H-6), 3.65 (dd, J = 10.9, 7.0
Hz, 1H, H-6b′), 3.53−3.47 (m, 1H, H-5), 3.45 (s, 3H), 2.05 (s, 3H).
13C{1H} NMR (126 MHz, CDCl3): δ 169.5, 165.8, 165.7, 165.4,
134.4, 134.3, 134.2, 134.1, 133.8, 133.7, 133.5, 133.4, 133.3, 133.2,
133.1, 132.8, 129.9, 129.8, 129.71, 129.69, 129.6, 129.2, 129.08,
129.05, 129.0, 128.9, 128.8, 128.44, 128.41, 128.3, 101.3 (C-1), 96.7
(C-1′), 83.3 (C-3), 77.7 (C-4), 74.9 (C-5), 73.0 (C-2), 72.1 (C-2′),
71.3, 71.2, 70.5 (C-3′), 69.8, 69.5 (C-4′), 69.0 (C-6), 68.7 (C-5′),
68.3 (C-6′), 55.4, 21.0. HRMS (ESI-TOF) (m/z): [M + Na]+ calcd
for C57H50Cl6O15Na, 1207.1179; found, 1207.1173.
Methyl 3,4,6-Tri-O-(o,p-dichlorobenzyl)-α-D-glucopyranosyl-(1→
6)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (58). Compound 32
(35.9 mg; 0.026 mmol) was dissolved in dry DCM (10 mL).
MeOTf (4.6 μL; 0.041 mmol) and TTBP (14 mg; 0.055 mmol) were
added, and the reaction mixture was reﬂuxed for 4 h at 40 °C, after
which the mixture was allowed to cool down to rt. KOtBu (6.8 mg;
0.041 mmol) was added, and the mixture was stirred at rt for 1 h, after
which the mixture was diluted with DCM (15 mL) and washed with
water (20 mL), sat aq NaHCO3 (20 mL), and brine (20 mL). The
organic layer was dried (MgSO4), ﬁltered, and concentrated under
reduced pressure. The crude product was puriﬁed by silica gel ﬂash
column chromatography (20% to 40% EtOAc in n-heptane), yielding
58 (22 mg; 0.019 mmol; 73%). TLC (EtOAc/n-heptane, 40/60 v/v):
Rf = 0.24.
1H NMR (500 MHz, CDCl3): δ 8.01−7.96 (m, 2H, CH
Ar), 7.96−7.90 (m, 2H, CH Ar), 7.90−7.84 (m, 2H, CH Ar), 7.56−
7.27 (m, 15H, CH Ar), 7.23−7.09 (m, 4H, CH Ar), 6.15 (t, J = 9.9
Hz, 1H, H-3′), 5.67 (t, J = 9.9 Hz, 1H, H-4′), 5.28 (dd, J = 10.1, 3.7
Hz, 1H, H-2′), 5.23 (d, J = 3.7 Hz, 1H, H-1′), 5.08−5.03 (m, 1H, H-
1), 5.01 (d, J = 12.8 Hz, 1H, CH2PhCl2), 4.83 (d, J = 12.8 Hz, 1H,
CH2PhCl2), 4.80 (d, J = 12.9 Hz, 1H, CH2PhCl2), 4.57 (d, J = 13.0
Hz, 1H, CH2PhCl2), 4.55 (d, J = 13.3 Hz, 1H, CH2PhCl2), 4.41 (d, J
= 13.3 Hz, 1H, CH2PhCl2), 4.28 (ddd, J = 10.3, 4.6, 2.2 Hz, 1H, H-
5′), 3.93 (dd, J = 11.8, 4.6 Hz, 1H, H-6a′), 3.84−3.71 (m, 4H, H-2,
H-3, H-5, H-6b′), 3.67 (dd, J = 10.7, 3.6 Hz, 1H, H-6a), 3.65−3.60
(m, 1H, H-4), 3.54 (dd, J = 10.6, 1.9 Hz, 1H, H-6b), 3.47 (s, 3H,
OMe), 2.65 (s, 1H, OH). 13C{1H} NMR (126 MHz, CDCl3): δ
165.83, 165.80, 165.4, 135.0, 134.7, 134.3, 133.7, 133.64, 133.58,
133.4, 133.22, 133.20, 133.14, 132.9, 130.2, 130.0, 129.9, 129.8, 129.7,
129.5, 129.1, 128.99, 128.98, 128.90, 128.88, 128.81, 128.5, 128.4,
128.3, 127.05−126.99 (m), 126.9, 98.6 (C-1), 97.1 (C-1′), 83.4 (C-
3), 77.2 (C-4), 73.3 (C-2), 72.1 (C-2′), 71.4, 71.0, 70.5 (C-5), 70.4
(C-3′), 69.7, 69.2 (C-4), 68.9 (C-6), 68.6 (C-5′), 65.6 (C-6′), 55.8
(OMe). HRMS (ESI-TOF) (m/z): [M + Na]+ calcd for
C55H48O14Cl6Na, 1165.1073; found, 1165.1048.
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